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Jorg Spence: Right to Know: A Diet of the Future Presently Upon Us

RIGHT TO KNOW: A DIET OF THE FUTURE
PRESENTLY UPON US
I. INTRODUCTION
In 1994, the U.S. government approved the first genetically modified
(“GM”)1 food product for marketing and sale.2 In the last decade, the
U.S. government has approved over fifty more GM food products.3 In
some parts of the world, particularly Europe, consumers have adamantly
rejected GM products, even as the research and development of these
foods has increased worldwide.4 In the United States, GM foods have
slipped into grocery stores virtually unnoticed by U.S. citizens, even
though the United States is the largest producer of these foods.5 The
1
Scientists are not in consensus about what term should be used to describe what is
commonly called “genetically modified.” For example, the Society of Toxicology (“SOT”),
a non-profit organization made up of scientists from academic institutions, government,
and industry, refuses to use “genetically modified” because it says that this term is
“misleading, since conventional methods of microbial, crop, and animal improvement also
produce genetic modifications . . . .” SOT ad hoc Working Group, The Safety of Genetically
Modified Foods Produced Through Biotechnology, 71 TOXICOLOGICAL SCIS. 2, 2 (2003)
[hereinafter SOT, Safety of GM Foods]. Instead, the SOT prefers to use the term
“biotechnology-derived.” Id. However, another source says that “biotechnology was
coined in 1919 by Karl Ereky, to apply to the interaction of biology with human
technology” and traditionally includes “beekeeping and cattle breeding.” Kimball R. Nill,
Technomic Publishing Co., biotechterms.org, at http://biotechterms.org/sourcebook/
saveidretrieve.php3?id=239 (last visited Jan. 4, 2005). Therefore, this Note uses the more
common “genetically modified” (“GM”) and “genetically engineered,” interchangeably.
Specifically, the definition of “genetically modified organisms” used herein is as follows:
“The modification of the genetic characteristics of a microorganism, plant or animal by
inserting a modified gene or a gene from another variety or species.” European
Environment Agency, EEA Multilingual Environmental Glossary, at http://glossary.eea.eu.
int/EEAGlossary/G/genetically_modified_organism (last visited Jan. 7, 2005). The second
part of this definition, which this Note does not use because of its narrowing effect, is as
follows: “Genetically modified organisms (GMOs) may be microorganisms designed for
use as biopesticides or seeds that have been altered genetically to give a plant better disease
resistance or growth.” Id.
2
U.S. Food and Drug Administration, List of Completed Consultations on Bioengineered
Foods, at http://www.cfsan.fda.gov/~lrd/biocon.html#list (last updated Sept. 21, 2004)
[hereinafter FDA List].
3
Id.
4
See infra notes 82-84 and accompanying text (regarding effective European consumer
movements opposing GM foods); see also Council for Biotechnology Information; Study Finds
Biotech Crops are Being Grown in 18 Countries and Researched in 45, BIOTECH WK., Jan. 5, 2005,
at 212.
5
See infra text accompanying notes 90-91 (regarding U.S. consumers’ ignorance
concerning GM foods); infra note 92 and accompanying text (regarding U.S. consumers’
ignorance concerning GM foods); infra note 95 and accompanying text (regarding U.S.
consumers’ ignorance concerning regulation of GM foods); see also Council for Biotechnology
Information; Study Finds Biotech Crops Are Being Grown in 18 Countries and Researched in 45,
BIOTECH WK., Jan. 5, 2005, at 212 (stating that the United States is the leading producer of
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United States has had limited exposure to GM foods issues and
therefore, as it enters into this dialogue, it would be prudent for it to pay
heed to the more formulated thoughts of Europe.6 Understanding the
discussion Europe has had on GM foods will help the United States more
thoughtfully sort out its own issues as its citizens become more aware of
GM foods, while simultaneously giving the United States insight on how
to effectively legislate so as to promote its trade relationships with
European countries.7
Although the current administration’s approach toward GM foods is
unquestioningly positive, as has been the case with past administrations,
many U.S. consumers who are aware of GM foods oppose them.8 U.S.
consumers oppose GM foods because of societal and moral concerns, as
well as health related concerns.9 For example, consider a mother whose
son is born prematurely, and as a result he has dealt with many health
problems. The most frightening health problems are his severe allergies
and sensitivity to food. Through a series of medical tests and a few
inadvertent trials resulting in error that nearly cost the boy his life, the
mother finally narrows down several foods that she knows are safe for
her son. By eating only these foods he can live free from fear of death by
allergic reaction. However, having extensively researched food and
allergies, the mother discovers that food manufacturers are genetically
modifying some foods. Although many sources have assured her that,
so far, GM foods that are properly on the market have not had any
known negative effects, the mother has also read that scientists are
unsure how genetic modification will affect allergies because allergies
are not yet well understood by science. She is now weary with fears that
she may expose her son to GM foods she thinks are “safe” but end up
being just different enough from the originals that they kill or seriously

biotech crops selling $27.5 billion in 2003-2004 followed by Argentina selling $8.9 billion,
China selling $3.9 billion, Canada selling $2 billion, and Brazil selling $1.6 billion).
6
See infra text accompanying note 7.
7
See infra notes 82-84 and accompanying text (regarding European opinion of GM
foods); infra notes 69-73 and accompanying text (describing, for example, non scientific
reasons many European citizens are opposed to GM foods); infra Part II.D.1 (describing the
debate between the United States and European Union at the WTO); infra text
accompanying notes 245-54 (describing how disclosure would improve trade with Europe).
8
See infra note 88 and accompanying text (describing American opposition to GM
foods); infra note 187 (describing Monsanto’s deep roots in Washington D.C. and the
administration’s consistent support of the biotech industry over the last several
presidencies).
9
See infra text accompanying notes 41-80 (explaining the myriad of concerns people
have with GM foods).
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harm him. Currently, the mother has no practical way to guard her son
from this risk because GM foods are not labeled.10
In response to consumer concerns, Congressmen Dennis Kucinich
proposed a series of bills in the summer of 2003 that would impose
greater regulation on GM foods.11 One of the proposed regulations, the
Genetically Engineered Right to Know Act (“GERKA”),12 proposed an
amendment to the Federal Food, Drug, and Cosmetic Act (“FFDCA”)13
requiring manufacturers to use labels to disclose food products that are
GM.14 While many U.S. consumers and legislators had supported this
bill requiring disclosure before it expired at the end of 2004, the U.S.
Administration is presently battling with the European Union at the
World Trade Organization (“WTO”) because of measures the European
Union has taken against foods imported into Europe, including a
requirement that GM foods be labeled.15 The U.S. Administration insists
that disclosure by labeling is unnecessary and a violation of free trade
because there is no scientific data to support a conclusion that GM foods
are harmful.16
There are several reasons why this response by the U.S.
Administration is insufficient.17 This Note addresses these reasons as it
considers why and how the United States should require disclosure of
GM foods. Part II of this Note provides background information on
labeling GM foods.18 Part III of this Note analyzes the statutory
authority and constitutionality of requiring disclosure of GM foods, as
well as an expired bill that would have required disclosure.19 Part IV of

This hypothetical, though completely plausible, is in fact fictional.
See infra note 88 (listing the proposed bills).
12
Genetically Engineered Right to Know Act, H.R. 2916, 108th Cong. (2003).
13
Federal Food, Drug, and Cosmetic Act, Pub. L. No. 108-68, 52 Stat. 1040 (codified as
amended in scattered sections of 21 U.S.C.).
14
See Genetically Engineered Right to Know Act, H.R. 2916, 108th Cong. (2003); Part
III.C (providing the text and an analysis of part of this bill).
15
See infra Part II.D.1 (discussing the dispute between the United States and Europe at
the WTO).
16
See infra notes 166-79 and accompanying text (regarding the United States continuing
to dispute with Europe even though the moratorium has been lifted).
17
See infra text accompanying notes 263-68 (describing philosophical and other nonscientific reasons that justify requiring disclosure of GM foods); supra Part I (describing a
hypothetical case in which a mother and her allergy-laden son demonstrate that the lack of
negative information does not necessarily justify a lack of disclosure when there is very
little information at all); infra note 261 and accompanying text (describing how it is a logical
fallacy to draw a conclusion based on a lack of information to the contrary).
18
See infra Part II.
19
See infra Part III.
10
11
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this Note offers several changes to the expired bill.20 Finally, Part V of
this Note concludes that Congress should again raise the issue of
disclosure of GM foods and should pass a modified version of the
expired GM bill containing provisions that are consistent with the goals
of disclosure and the information currently available on GM foods.21
II. BACKGROUND
Analyzing the legal concerns related to labeling GM foods requires
consideration of a broad range of information.22 Section A of this Part
offers a basic explanation of GM foods, including both scientific and
public understandings and opinions of these foods.23 Next, Section B
explains how the First Amendment impacts commercial labeling.24
Section C outlines the reasons the government may require labeling and
the rationale undergirding voluntary labeling.25 Finally, Section D
explains the two most significant legal issues dealing with GM foods:
the dispute at the WTO over GM foods and the possibility of lawsuits
resulting from voluntary labeling.26
A. GM Foods
Every living cell contains deoxyribonucleic acid (“DNA”), which
functions as instructional information.27 The DNA collectively comprises
a genome, which is one complete copy of an organism’s genetic
material.28 The organization of the DNA within the genome, referred to
as the “genetic code,” is primarily responsible for gene expression, which
is largely determinative of the traits an organism will display.29
Scientists are able to identify particular genes for particular traits in one
genome, remove these genes, and transfer them into other genomes.30 A
gene that is transferred is called a “transgene.”31 The cell from which a
See infra Part IV.
See infra Part V.
22
See infra Part II.
23
See infra Part II.A.
24
See infra Part II.B.
25
See infra Part II.C.
26
See infra Part II.D.
27
WAYNE M. BECKER ET AL., THE WORLD OF THE CELL 408 (3rd. ed. 1996).
28
Id. at 421.
29
Id. at 436. For a general discussion of plant genetics, see PETER H. RAVEN ET AL.,
BIOLOGY OF PLANTS 121-49 (5th ed. 1992).
30
Krista Weidner, Science in Your Shopping Cart, PENN STATE AGRIC., Fall 2002/Winter
2003, at 19.
31
Kimball R. Nill, Technomic Publishing Co., biotechterms.org, at http://biotechterms.
org/sourcebook/saveidretrieve.php3?id=1906. “Transgene” is defined as follows: “A
20
21
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transgene is removed is the “donor,” and the cell into which a gene is
transferred is the “host.”32 The consequences of this small move, which
is “genetic modification,” can result in many interesting and beneficial
products.33
The main purpose of most GM crops produced to date is to increase
crop yield.34 Many proponents of GM foods are hopeful that increased
yields in food resulting from genetic modification can help feed the poor
of the world.35 Beyond the main purpose of increasing crop yield, the
‘package’ of genetic material (i.e., DNA) that is inserted into the genome of a cell via gene
splicing techniques. May include promoter(s), leader sequence, termination codon, etc.”
Id.
32
Thomas O. McGarity, Seeds of Distrust: Federal Regulation of Genetically Modified Foods,
35 U. MICH. J.L. REFORM 403, 406 (2002). This process can be done in several ways:
(1) direct DNA uptake by the plant cells mediated by chemical or
electrical treatments; (2) microinjection of DNA directly into plant
cells; (3) biolistics, or firing tiny metal particles coated with the DNA
of interest into plant cells; and (4) infecting the plant with a bacterium
that scientists have modified to carry the DNA into plant cells.
Id.
33
See infra notes 34-40 and accompanying text.
34
Ricki M. Helm, Food Biotechnology: Is This Good or Bad? Implications to Allergic Diseases,
90 ANNALS OF ALLERGY, ASTHMA, & IMMUNOLOGY 90, 91 (June 2003). The first approved
GM food to hit the market was the Flavr Savr tomato, which made its debut in 1994, and its
purpose was “delayed softening due to reduced pectin degradation.” FDA List, supra note
2. These tomatoes can stay fresher for longer because they can stay firm on the vine longer.
Consumer Safety Officer, Biotechnology Policy Branch, HFS-206, Department of Health
and Human Services, FDA, to Acting Director, Office of Premarket Approval, HFS-200,
Department of Health and Human Services, FDA (May 17, 1994), available at
http://www.cfsan.fda.gov/~acrobat2/bnfMFLV.pdf. The Flavr Savr tomato was followed
by Roundup Ready soy beans and cotton, which are designed to resist herbicides and to act
as pesticides. Weidner, supra note 30, at 19, 20; FDA List, supra note 2.
Genetic modification has accomplished the goal of increasing crop yields in several
ways. For example, plants with herbicide resistance can tolerate chemical herbicides that
kill weeds. McGarity, supra note 32, at 412. Other plants are engineered to contain Bt, a
pesticide that makes plants resistant to insects. Id. at 411. Still others are vaccinated,
making them resistant to plant viruses and diseases. Id. at 411. Some are even designed in
such a way that they are able to grow in unusual temperatures and soils. Id. at 413. One of
the more interesting genetic engineering inventions is the extraction of a gene responsible
for the production of an antifreeze chemical, found in the genome of a flounder (a cold
water fish) that is added to the genome of a tomato, resulting in tomatoes that are resistant
to freezing weather. See Valerie Janlois, Is There a Fish Gene in Your Tomato?, ROCHESTER
DEMOCRAT AND CHRON., June 10, 1999, at 9A. For a step by step pictorial description of
how scientists manage to do this genetic modification, see BBC, GM Science: How to Add a
Fish Gene to a Tomato, available at http://www.bbc.co.uk/science/genes/gm_genie/gm_
science/index.shtml (last visited Jan. 4, 2005).
35
Haroon Ashraf, UK Ethicists Say GM Foods Could Help the Poor, 361 THE LANCET 2051,
2051 (June 14, 2003). Genetic modification as a means to solve hunger issues actually
became quite controversial in late June and early July of 2003, when President George Bush
said that the European Union’s ban on GM food contributed to the famine in Africa.
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reduced use of pesticides and herbicides to protect GM crops may be
more environmentally friendly and may result in a decreased risk of
superweeds.36
The future goals for GM foods are aimed at increasing the nutritional
value of foods.37 Some researchers are looking into changing plants in
such a way that they can be used as pharmaceuticals, botanical drugs,
and functional foods.38 Other researchers are trying to use genetic
engineering to increase the levels of antioxidants in foods or to reduce
the amount of trans fats.39 Finally, some developers are focusing on
improving the flavor of certain crops.40

Michael Thurston, EU Moves to Ease Transatlantic Row Over Biotech Foods, AGENCE FRANCE
PRESSE, July 2, 2003. In response, Pat Cox, the president of the European Parliament,
pointed out that the European Union gives three times more food to Africa than the United
States, stating “we don’t need to be lectured on humanitarian priorities.” Id. Furthermore,
it is unclear that producing more food will do anything at all to solve hunger issues in the
world. See Neil E. Harl, Biotechnology Policy: Global Economic and Legal Issues, 12
WILLAMETTE J. INT’L L. & DISPUTE RES. 1, 21-22 (2004) (describing how hunger problems
result from income, not a lack of food).
36
Jon Van, Biotech-crop Firms Seek to Breach Barriers, CHI. TRIB., Nov. 27, 2004, at C3
(describing how agricultural chemical producers incorrectly thought that environmentalists
would embrace genetically modified products because they would reduce the need to
spray chemicals to control pests); Helm, supra note 34, at 93; Norman Ellstrand, Superweed
Dreams, NEW SCIENTISTS, Oct. 23, 2004, at 54 (reviewing the book entitled Introgression from
Genetically Modified Plants into Wild Relatives by H. C. M. den Nijs, et al.). A superweed is
“[a] wild plant that has been accidentally pollinated by a genetically-modified plant and
now contains that plant’s abilities to resist herbicides and kill insects.” Paul McFedries, The
Word Spy, at http://www.wordspy.com/words/superweed.asp (posted on Feb. 16, 2000).
For example, Allison Snow of Ohio State University found that GM sunflowers that
produce a pesticide have crossed with weeds of sunflowers, and now the weeds also
produce the pesticide. Sandi Rutkowski & Natalie Corvington, Genetically Modified Crops
May Pass Helpful Traits to Weeds, Study Finds, 21 OHIO ST. SYNERGY, 2002-2003, at 10,
available at http://www.biosci.ohio-state.edu/documents/synergy/2002-2003/snow.php
(last visited Jan. 4, 2005).
37
Helm, supra note 34, at 91. See also generally Bo Lonnerdal, Genetically Modified Plants
for Improved Trace Element Nutrition, THE J. OF NUTRITION, 1490S (2003) (describing scientific
techniques that can be used to increase the iron and zinc in plant foods). One example of a
product with increased nutritional value due to genetic modification is “golden rice,”
which is vitamin A fortified rice—a product that scientists hope can help cure the vitamin
A deficiencies in cultures that rely on rice as a staple food. Bruce Schultz, From LSU
AgCenter . . . . ‘Golden Rice’ Targets Malnutrition, DELTA FARM PRESS, Nov. 26, 2004, at 47;
Weidner, supra note 30, at 19, 23.
38
See llya Raskin et al., Plants and Human Health in the Twenty-First Century, 20 TRENDS IN
BIOTECHNOLOGY 522 (Dec. 2002); see also Harl, supra note 35, at 5-8 (describing
biopharmaceutical issues in the United States).
39
See Monsanto Company, Monsanto Imagine, at http://www.monsanto.com/
monsanto/layout/products/default.asp (last visited Jan. 4, 2005). See also generally M.E.
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With endless possible improvements to foods come endless possible
threats.41 In 2003, the Society of Toxicology (“SOT”) published a
thorough analysis of the possible threats posed by genetic modification.42
The SOT maintains that, although there is no evidence of any adverse
effects resulting from GM foods so far and although these foods are
likely as safe as traditional foods, assessing the safety of more complex
GM foods that are unlike any traditional foods could pose a greater
challenge.43 Therefore, the emergence of completely new foods will
require new toxicological methodologies to ensure safety.44 With these
considerations in mind, the SOT report examined the potential dangers
raised by the use of biotechnological science to produce GM foods.45
The dangers listed by the SOT range from the safety of transgenes to
concerns that the GM process will negatively impact the nutrition of the
host.46 Some scientists are concerned that transgenes themselves may be
unsafe, or that the antibiotic “markers” contained within many
transgenes may lead to bacterial and human resistance of antibiotics,
though the SOT generally dismisses these concerns.47 The more
complicated concern is that the product encoded by transgenes in the
host will pose risks, such as the inadvertent production of toxins.48
Furthermore, the randomness with which transgenes are inserted into
hosts could cause problems such as pleiotropic and insertional

Verhoeyen et al., Increasing Antioxidant Levels in Tomatoes Through Modification of the
Flavonoid Biosynthetic Pathway, 53 J. EXPERIMENTAL BOTANY 2099 (2002).
40
Helm, supra note 34, at 94.
41
See infra notes 42-44, 47-54 and accompanying text.
42
SOT, Safety of GM Foods, supra note 1, at 2.
43
Id. The premise of this conclusion by the Society of Toxicology is the concept of
“substantial equivalence”—the assumption that new plants or animals are safe if they are
not “significantly different from comparable, nonengineered plants or animals used to
produce food that is generally considered to be safe for consumers.” Id.
44
Id.
45
See infra notes 47-54 and accompanying text.
46
See infra notes 47-54 and accompanying text.
47
SOT, Safety of GM Foods, supra note 1, at 3. The SOT quickly dismisses the concern that
a transgene itself is unsafe because a transgene is simply DNA, which is not itself toxic. Id.
In fact, DNA actually plays a beneficial role in the immune system and the gut function. Id.
at 3-4. Furthermore, scientists are not too concerned with the threat posed by “markers”
because the chances of developing resistance are small, the impact negligible, and scientists
are now able to avoid using these markers in most instances. Id. at 5.
48
Id. at 4. One possible risk is from the production of toxins by the plant. Id. For
example, some plants are encoded to produce the Bt pesticide. Id. So far this has been
unproblematic, however, the SOT suggests that each new plant introduced with a gene to
produce such a product should be tested for any potential problems on a case-by-case
basis. Id.
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mutagenic effects.49 Another potential problem is that these new plants
will contain unidentified allergens, with effects that could range from
mild to deadly.50 Scientists have made some progress in the detection of
49
Id. at 5. Pleiotropic effects are changes in the phenotype of the host by a gene, and
insertional mutagenic effects are where the insertion of the new gene causes changes in the
expression of other genes. Id. Usually these effects are apparent in the host plant and so
there is very little possibility that such effects would result in increased toxins without
being detected before marketing. Id. However, toxicology does have limited predictive
abilities. Id. Toxicology’s limitations are demonstrated by a case occurring in the late
1980’s and early 1990’s where some scientists thought that the genetic modification of an
amino acid tryptophan supplement resulted in the production of increased levels of a
toxicant in the supplement that was responsible for the deaths of at least thirty-seven
people. Id.
50
Id. at 4. Allergens are not new, but rather are already contained within many of our
conventional foods. Id. Allergens are molecules that induce the production of IgE, which
binds to certain cells causing sensitization. Helm, supra note 34, at 91. Once a person is
sensitized, subsequent exposure to the allergen causes the body to produce histamine,
which results in an allergic response that can range between mild itching or swelling to
deadly anaphylaxis. Id. There are many unknowns regarding allergens, such as the dose
threshold of sensitization and of allergic reaction. Id. at 92. Also unknown is a reliable
method for predicting the allergenic risk of novel proteins. Id. at 91. However, there are
some known characteristics of allergens that can allow scientists to begin to detect them.
Id. The most prominent trait of allergens is the stability of the protein; in other words, its
resistance to heat and enzymatic degradation. Id. The World Health Organization has
described other approaches to identifying allergy sources, which include characterizing
amino acid sequences, developing more exact sequence screening by the identification of
those amino acid sequences that define allergens, and using animal models. Anita Bakshi,
Potential Adverse Health Effects of Genetically Modified Crops, J. TOXICOLOGY & ENVTL. HEALTH
211, 211 (2003). There are two prominent examples of allergens created, and then detected,
in GM foods based on characteristics that are common in allergens. The first is the StarLink
Corn, which has caused a major stir in the media in the last three years. See, e.g., Chris
Clayton, Starlink Corn Still Shows Up, OMAHA WORLD HERALD, July 30, 2003, at 1d; Andrew
Harris, Corn Rows, BROWARD DAILY BUS. REV., Sept. 18, 2002, at A8; Anthony Shadid, Blown
Profits Genetic Drift Affects More than Biology—US Farmers Stand to Lose Millions, THE BOSTON
GLOBE, Apr. 8, 2001, at G1; David Roeder, Suit Targets Corn Developer; Lax Safeguards for
Modified Product Charged, CHICAGO SUN-TIMES, Dec. 5, 2000, at 54; Marc Kaufman, Biotech
Critics Cite Unapproved Corn in Taco Shells; Gene-Modified Variety Allowed Only for Animal
Feed Because of Allergy Concerns, THE WASHINGTON POST, Sept. 18, 2000, at A02. Starlink
corn is the result of the toxin Cry9c being introduced into seed corn DNA in order to
provide corn with resistance to the corn borer. Helm, supra note 34, at 94. This corn was
approved only for animal consumption but not approved for human consumption because
its slow digestion made it potentially allergenic. SOT, Safety of GM Foods, supra note 1, at 5;
Krista Weidner, GMOs in the News: Starlink Corn, PENN STATE AGRIC., Fall 2002/Winter
2003, at 22 (discussing how farmers were supposedly told that the corn was not meant for
human consumption, but somehow the message did not get across to them clearly; the
result was contamination of human food supplies and criticism of the methods of
regulation). In fact, its accidental introduction into a corn supply meant for human
consumption was the possible cause of several illnesses, and StarLink corn has since been
recalled and lawsuits have emerged over the issue. SOT, Safety of GM Foods, supra note 1, at
5; Clayton, supra; Harris, supra. The other example is the introduction of a protein from
Brazil nuts into soybeans to improve the nutrition of soybeans. Helm, supra note 34, at 94.
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allergens.51 However, the information is still sparse and, coupled with
the potentially deadly result of allergies, there is no guarantee of safety.52
A final concern is the possibility that genetic modification will reduce the
nutritional value of the host.53 Nutritional changes detected thus far
have not necessarily been significant; however, developers of GM foods
should be aware that genetic engineering can result in unexpected
changes to the nutrition and safety of foods.54
Because the impact of genetic modification of food is far-reaching,
further research is necessary to determine all of the effects of GM foods.55
The SOT found that primary areas in need of further research are
developments in methods for testing whole foods (rather than just
comparing single components) for allergen identification and methods
for understanding proteins, gene expression, and the metabolites of
plants and microbes.56 One possible solution is that “[a]n information
and communication technology-based multidisciplinary framework
could be put into place to educate the public on foods from genetically
modified crops . . . .”57 This framework would include the tracking of
biotech foods so that these foods would be monitored from the seed all
the way to marketing.58
Regardless of the opinion of many scientists that there is still work to
be done in order to ensure and maintain safety in the production of GM
foods, some scientists maintain that this new technology is very safe and
Scientists were able to determine that the introduced protein was in fact an allergen by
using a decision tree together with the serum from individuals allergic to Brazil nuts. Id.;
infra note 59 (discussing decision trees).
51
Helm, supra note 34, at 95.
52
Id.
53
SOT, Safety of GM Foods, supra note 1, at 6. For example, Roundup Ready soybeans
have a greater amount of the antinutrient trypsin inhibitor than in conventional soybeans.
Id. Also, Roundup Ready soybeans have reduced amounts of two out of the three major
phytoestrogens found in soybeans. Marc Lappe, Biotechnology and Agriculture, 10 MICH. ST.
U. DETROIT C. L. J. INT’L L. 39, 39 (Spring 2001).
54
Lappe, supra note 53, at 39. There are many more examples of unexpected changes
that have occurred in plants as a result of transferring genes. Taking Stock, THE ECOLOGIST,
July/August 2003, at 32. For example a gene that codes for the red pigment in maize was
transferred to a petunia, and the petunia not only turned red, it also had more shoots, was
less fertile, and was more resistant to fungus. Id. Another example is a yeast that was
genetically engineered to increase fermentation, but which also produced a toxin that was
thirty times greater than in the conventional equivalent. Id.
55
SOT, Safety of GM Foods, supra note 1, at 7.
56
Id. These research developments suggested by the SOT are necessary to detect
unexpected changes resulting from bioengineering. Id.
57
Helm, supra note 34, at 96.
58
Id.
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may even decrease risks posed by food.59 However, the general public,
as well as many scientists, are concerned not just with the impact of GM
foods on human health, but also with the possible detrimental effects
that genetic modification may have on the environment.60 Some
members of the public also raise moral and religious objections to genetic
modification and express social concerns relating to the control of the
world’s food supply by those who have patented genetic modification
techniques.61
Potential environmental harms created by genetic modification
include the growth of superweeds,62 increased use of pesticides,63 genetic
pollution,64 and a general risk of adverse impacts on biodiversity.65
59
Andrew Cockburn, Assuring the Safety of Genetically Modified (GM) Foods: The
Importance of an Holistic, Integrative Approach, 98 J. BIOTECHNOLOGY 79, 85-93 (2002). The
assurance of safety of GM foods from scientists is due to the intricate safety assessment
procedures scientists have set up for these foods. Id. In particular, scientists have
developed decision trees which include assessment of the host crop, the transgene, and the
gene product. Id. Some scientists, who assume substantial equivalence and take the stepby-step decision tree approach, feel confident in concluding that GM foods are just as safe
as their traditional counterparts, which have never undergone the same rigorous testing.
Id. Some data suggests that allergens in food can be identified and removed by genetic
modification, indicating that genetic modification may even increase the safety of foods.
See generally Eliot M. Herman et al., Genetic Modification Removes an Immunodominant
Allergen from Soybean, 132 PLANT PHYSIOLOGY 36 (May 2003) (describing scientific evidence
that Gly m Bd 30 K, a soybean allergen, may be removed without significantly altering the
growth and maturation of the soybean plant).
60
See infra notes 62-69 and accompanying text.
61
See infra notes 70-76 and accompanying text.
62
Keep Britain GM-Free, THE ECOLOGIST, July/Aug. 2003, at 38 [hereinafter Keep Britain
GM-Free]. Not only can genes from GM plants be transferred to related weeds, these GM
plants can themselves act like weeds. Id. For example, the GM oilseed rape resistant to
herbicides has been created and grown in Canada since 1998 and now GM oilseed rape is
out of control. Id.; Rutkowski & Corvington, supra note 36, at 10 (regarding sunflower
superweeds).
63
Keep Britain GM-Free, supra note 62, at 38. Insects can quickly adapt to pesticides, so
that plants that produce the pesticides will no longer be effective and additional pesticides
will be required. Id.
64
Id. GM crops may reduce overall diversity by contaminating species that are wild. Id.
For example, in the case of oilseed rape, genes from modified crops can “jump” the species
barrier and cause mutations. Antony Barnett, GM Genes ‘Jump Species Barrier,’ THE
OBSERVER, May 28, 2000, at 1 (discussing the four year study of German zoologist HansHinrich Kaatz, who found that the transgene used in oilseed rape had transferred to
bacteria living in the inside of the guts of bees). Kaatz did not publish this information in a
scientific journal for fear that he would be ostracized from the scientific community much
like Dr. Arpad Pustzai, who was fired for publishing damaging information on the effects
of GM potatoes to the lining of rats’ stomachs. Id.; see also infra note 75 (discussing a case in
Canada where Monsanto sued Percy Schmeiser for using its GM rape seed).
65
Blake A. Biles, Agriculture Biotechnology: The U.S. Perspective, 18 NAT. RESOURCES &
ENV’T 12, 12 (Summer 2003). The concern is that GMOs would reduce the gene pool due to
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Likewise, genetic modifications may pose risks to non-target
organisms.66 For example, plants encoded to produce the pesticide Bt
have been reported to cause some unfavorable health effects in
butterflies, moths, beetles, and flies.67 Greenpeace is campaigning
against genetic engineering because scientists do not have adequate
information on how GM organisms will affect the environment, and
because once GM organisms are introduced into the environment, they
cannot be recalled.68 Organic farmers are also opposed to genetic
engineering because the general approach organic farmers have toward
the environment precludes this rather domineering attitude.69
The Agriculture and Environment Biotechnology Commission
(“AEBC”), an organization set up to give independent advice to the UK’s
government regarding biotechnology, recently reported that many lay
people were morally opposed to GM animals.70 Moral objections to
genetic engineering include that it is like “playing God,”71 it “violates the
integrity of living organisms” by showing no respect for the “otherness”
of animals and by using them purely as an object or a research
the promotion and use of fewer types of seeds, which could eventually result in the loss of
knowledge and cultivation of local varieties and lead to their ultimate demise. Kim JoDene
Donat, Note, Engineering Akerlof Lemons: Information Asymmetry, Externalities, and Market
Intervention in the Genetically Modified Food Market, 12 Minn. J. Global Trade 417, 423-24
(2003); infra note 75 (regarding the importance of saving seed to maintain biodiversity).
66
SOT, Safety of GM Foods, supra note 1, at 6.
67
Bakshi, supra note 50, at 219. Specifically, some evidence indicates that Bt is harmful
to Monarch butterfly larvae. SOT, Safety of GM Foods, supra note 1, at 6. However, the
actual amount and level of exposure that the Monarch butterfly larvae has to Bt plants is
limited, so that the actual harm is likely to be minimal, particularly as compared to the
spraying of Bt. Id. at 6-7.
68
Greenpeace, Genetic Engineering, at http://ge.greenpeace.org/international_en/
campaigns/intro?campaign%5fid=3942 (last visited Jan. 4, 2005) [hereinafter Greenpeace,
Genetic Engineering].
69
Henk Verhoog, Naturalness and the Genetic Modification of Animals, 21 TRENDS IN
BIOTECHNOLOGY 294, 296 (2003). To organic farmers, farming has a “cognitive component,
which is ecologically and holistically inspired” and an “emotive component, related to a
non-anthropocentric, positive attitude towards nature, in which the animal (and nature in
general) is seen as a more or less ‘autonomous’ partner with whom the farmer should
cooperate.” Id. This approach also includes a “[r]espect for species barriers.” Id.
70
See Verhoog, supra note 69, at 294. Henk Verhoog of the Louis Bolk Institute explains
some of the ethical arguments against the use of genetic modification of animals and
plants, dealing primarily with the intrinsic morals concerns. Id.; Agriculture and
Environment Biotechnology Commission, Animals and Biotechnology, Sept. 3, 2002, at
http://www.aebc.gov.uk/aebc/pdf/animals_and_biotechnology_report.pdf.
71
Verhoog, supra note 69, at 294-96.
In other words, genetic engineering is
“blasphemous” or is “human hubris.” Id.; Alliance for Bio-Integrity, Why the Genetic
Engineering of Our Food Offends Principles of Most Religions, at http://www.biointegrity.org/RelReject.html (last visited Jan. 4, 2005).
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instrument,72 and that it is “unnatural.”73 Some people are opposed to
genetic modification because it entails patenting life, which they believe
should not be allowed because it gives corporations too much control
over life.74 Still others focus their concern on the impact genetic
modification has on small farmers and farmers in developing nations.75
Verhoog, supra note 69, at 294; see also Ron Epstein, Genetic Engineering and Its Dangers,
at http://online.sfsu.edu/%7Erone/GEessays/gedanger.htm#Ethical (revised Mar. 2004).
Ron Epstein, Research Professor of Berkeley, describes biotechnology-related concerns as
they run into ethical and religious beliefs. Id. For example, he says that genetic
engineering disregards the intrinsic value of living organisms, which allows for a
proprietary view towards living things. Ron Epstein, Redesigning the World: Ethical Issues
About Genetic Engineering, in ETHICAL ISSUES IN BIOTECHNOLOGY 47, 58-59 (Richard Sherlock
& John Morrey eds., 2002). He also says that the very assumptions of Buddhism consider
the risks of biotechnology as not just physical risks but also spiritual risks, which is cause
for great concern for Buddhists. Ron Epstein, Talk entitled “Buddhism and Biotechnology”
delivered as part of “Spiritual Dimensions of our Technological Future” AHIMSA Sixth
Annual Conference, International House, University of California at Berkeley (Oct. 3, 1998)
at
http://online.sfsu.edu/~rone/GEessays/Buddhism%20and%20Biotechnology.htm.
Epstein discusses four assumptions of Buddhism that are incompatible with biotechnology.
Id. First, is the notion of ahimsa, which means “non-harming” and “is the principle of
respect for the intrinsic value of the life of all sentient beings, not just human life.” Id. This
notion precludes use of sentient beings as instruments, a practice that is necessary for
biotechnology. Id. The second is transcendence, which is a notion that science cannot
address. Id. The third is that “the cosmos is an open system,” which is opposed to
scientific research that assumes the cosmos is a closed system; the open system assumption,
therefore, sees science as much more limited than do those people coming from a scientific
methodology viewpoint. Id. Finally, Buddhism is non-Cartesian, which means that
biotechnology will affect not only the physical but also the spiritual, because the two are
not distinct from each other. Id.
73
Verhoog, supra note 69, at 294-95. Genetic modification is “unnatural” in that it is
counterintuitive to common sense, and that speaking of something as being natural or
unnatural is never just descriptive—there is always a normative component. Id.
74
See, e.g., Greenpeace, Genetic Engineering, supra note 68. Greenpeace states the
following:
We . . . oppose all patents on plants, animals and humans, as well as
patents on their genes. Life is not an industrial commodity. When we
force life forms and our world’s food supply to conform to human
economic models rather than their natural ones, we do so at our own
peril.
Id.; see also ActionAid, Food Rights, at http://www.actionaid.org/docs/FoodRights2004.pdf
(last visited Jan. 7, 2005) [hereinafter ActionAid, Food Rights] (describing how patents on
plant varieties are monopolized by four big companies, so that poor farmers can no longer
freely save, exchange and sell seeds). ActionAid is an international development agency
trying to eradicate poverty by forming partnerships with poor people from whom they
learn so as to help them. ActionAid, About Us, http://www.actionaid.org/aboutus/index.
html (last visited Jan. 4, 2005).
75
See ActionAid, Food Rights, supra note 74. In its briefing papers for the WTO
ministerial conference for 2003, ActionAid made the following statements:
Traditionally, poor farmers reduced the risk of total crop failure by
planting a wide range of crop varieties. Their use of seeds with
72
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These people argue that, based on the present status of intellectual
property law, genetic engineering benefits the rich, not the hungry, by
making small farmers more dependent on agribusiness.76

differing traits allows future generations to select and breed plants that
are best adapted to changing environmental, economic, and social
pressures. In contrast, intellectual property laws, by encouraging the
development of seeds with a large commercial potential have lead to
an increase in monoculture and the reduction of environmental
heterogeneity. This poses a danger to farmers and food security
because of the increased risk of wholesale crop failure inherent in
agriculture using such a narrow genetic base. For most developing
countries, widespread crop failure spells nothing less than disaster.
ActionAid, Trade Related Intellectual Property Rights, at http://www.actionaid.org.uk/wps/
content/documents/trips2.pdf (Jan. 4, 2005). See also generally Shubha Ghosh, Traditional
Knowledge, Intellectual Property, and Indigenous Culture, 11 CARDOZA J. INT’L & COMP. L. 497
(describing the conflict between intellectual property rights and traditional knowledge).
A current example of the effect that patenting practices can have on small farmers is
the effect it has had on Percy Schmeiser. In May 2004, the Supreme Court of Canada
handed down a 5-4 decision in which it determined that Monsanto’s patent of Roundup
Ready Canola is patentable, rejecting Schmeiser’s argument that the subject matter in the
patent is unpatentable. Monsanto Canada Inc. v. Schmeiser, 2004 S.C.C.D.J. Lexis 31, 15-17.
The court also concluded that Schmeiser “used” Monsanto’s patent when he intentionally
collected those seeds that fell on his property that he knew were Roundup Ready Canola
seeds, and then proceeded to use them in the next year. Id. at 33-48. However, the court
decided 9-0 that Monsanto should not be awarded damages because it could not prove that
Schmeiser in any way benefited from using the seeds. Id. at 51. The dissent argued that
because the patent did not include the regenerated plant or its progeny, and therefore,
because of the lack of notice given to the public, the patent should not extend to use of the
plant. Id. at 56-63, 74.
The results of the case are unclear, but Percy Schmeiser counts his case a victory in a
couple different ways. First, he does not have to pay damages, and likewise, it may be
difficult for Monsanto to successfully sue farmers in the future because, after this case, it is
clear that Monsanto must prove that the farmer benefited from the illegal use of the patent
in order for Monsanto to receive damages. Percy Schmeiser, Monsanto v. Schmeiser, Percy
Schmeiser Claims Moral and Personal Victory in Supreme Court Decision,
http://www.percyschmeiser.com/decisioncomments.htm (last visited Jan. 4, 2005).
Furthermore, Schmeiser surmises that if Monsanto owns the patent on the plants, then
Monsanto should also be responsible for them. Id. Accordingly, Schmeiser’s wife, Louise,
has filed suit against Monsanto in a small claims court for $140, the amount it cost her to
remove Roundup Ready Canola seeds from her nearby organic garden. Monsanto v.
Schmeiser, Schmeiser’s Wife Takes on Monsanto, http://www.percyschmeiser.com/Wife.htm
(last visited Jan. 4, 2005).
The Schmeisers are not the only small farmers Monsanto has sued. A farmer from
North Dakota, Rodney Nelson, spent over $200,000 on attorney’s fees when Monsanto
unsuccessfully sued him for saving Roundup Ready soya beans from the previous year.
Where Did GM Go Wrong?, WESTERN MORNING NEWS (Plymouth), Oct. 14, 2003, at 32. What
is worse is that the Roundup Ready soya Nelson used produced substantially less yield
than the conventional seed. Id.
76
See generally Carlos Scott Lopez, Intellectual Property Reform for Genetically Modified
Crops, 20 J. CONTEMP. HEALTH L. & POL’Y 367 (2004) (describing how the main problem with
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Furthermore, scientists disagree on a basic assumption regarding
genetic engineering: whether GM foods should be assessed based on
substantial equivalence.77 Substantial equivalence assumes that new
plants or animals are safe if they are “not significantly different from
comparable, nonengineered plants or animals used to produce food that
is generally considered to be safe for consumers.”78 Although many
scientists agree that substantial equivalence is a reasonable method to
use to determine the safety of new products developed by genetic
modification, some scientists do not agree with this basic assumption
because genetic modification often produces unintended and potentially
undetected results.79 Also, some scientists do not adhere to the
substantial equivalence assumption because the term “substantial

genetically modified crops is that they are inconsistently and inadequately managed
because of the current intellectual property system, and offering five guiding principles for
creating a new framework for intellectual property law as it pertains specifically to
genetically modified crops). See also Katrin Dauenhauer, Activists Say U.S. Manipulating
Meeting to Promote GM Food, INTER PRESS SERVICE, June 23, 2003. Anuradha Mittal of Food
First, an organization based in California, said:
It is a myth that science and technology play a critical role in reducing
hunger in developing countries. The claim that we must accept
genetically engineered foods if we are to feed the poor in the Third
World is simply ‘poorwashing’ . . . . Hunger is a complex phenomenon
that cannot be solved by technology alone. We need political
commitment and not technology. Countries suffering from hunger
need basic social economic change.
Id. Opposition to GM foods, and more generally to subsidies to American and European
farmers, resulted in riots in Cancun, Mexico disrupting the WTO trade talks being
conducted there in September of 2003. Dennis Byrne, The Problem with Subsidies from
Governments, CHI. TRIB., Sept. 15, 2003, at 19; Letta Tayler, Bracing for Violence; Mexicans Fear
Riots at WTO Summit, NEWSDAY (NEW YORK), Sept. 12, 2003, at A22. Protestors in India
destroyed a Monsanto Greenhouse, which according to M.D. Nanjundaswamy, president
of the farmers’ union Karnataka Rajya Raitha Sangha, was done “to protest against the
WTO meeting at Cancun and to oppose the setting up of monopolies by multinational
companies.” Subramaniam Sharma, Monsanto India’s Shares Decline After Attack on
Greenhouse, BLOOMBERG NEWS, Sept. 12, 2003, available at LEXIS, News Library, ALLBBN
File.
77
See infra notes 78-80 and accompanying text.
78
SOT, Safety of GM Foods, supra note 1, at 2.
79
Many scientists believe that substantial equivalence is reasonable. SOT, Safety of GM
Foods, supra note 1, at 2 (stating that support for the use of substantial equivalence is part of
the safety assessment of biotechnology-derived foods); Cockburn, supra note 59, at 79
(stating that international efforts for determining safety have focused on changes in
nutrients, anti-nutrients and toxicity as compared to the traditional counterparts).
However, many scientists question substantial equivalency. Lappe, supra note 53, at 39
(explaining that “there are subtle differences between engineered and nonengineered
crops,” which “calls into question the issue of equivalence”); see supra note 54 and
accompanying text (regarding unexpected changes resulting from genetic modification).
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equivalence” is not clearly defined, leaving room for misguided
interpretation.80
The public perception of GM foods, like that of the scientific
community, is certainly not uniform, especially across the Atlantic.81 In
Europe the public sentiment has been quite negative.82 Between 1992
80
Sheldon Krimsky & Nora K. Murphy, Biotechnology at the Dinner Table: FDA’s
Oversight of Transgenic Food, 584 ANNALS AM. ACAD. POL. & SOC. SCI. 80, 92 (Nov. 2002);
McGarity, supra note 32, at 430 (saying that critics to the substantial equivalence doctrine
are particularly disturbed by its subjectivity in that there is no standardized objective test to
measure what is substantial and what is not).
81
Compare infra notes 82-84 and accompanying text, with infra notes 85-88 and
accompanying text.
82
Maria K. Magnuson & Ulla-Kaisa Koivisto Hursti, Consumer Attitudes Towards
Genetically Modified Foods, 39 APPETITE 9, 10 (2002) (reporting studies done on consumer
attitudes towards GM technology).
At first, Monsanto was careful, realizing that it needed to gradually win the trust of
the public. Kurt Eichenwald, Redesigning Nature: Hard Lessons Learned; Biotechnology Food:
From the Lab to Debacle, THE NEW YORK TIMES, Jan. 25, 2001, at A1. However, in 1990,
Robert Shapiro was named head of the agriculture division, and he took a very aggressive
approach, which was strategically a very bad decision. Id. Will Carpenter, who was the
head of Monsanto’s strategy group until 1991, said: “Somewhere along the line, Monsanto
specifically and the industry in general lost the recipe of how we presented our
story . . . . When you put together arrogance and incompetence, you’ve got an unbeatable
combination. You can get blown up in any direction. And they were.” Id. American critic
of GM Foods Jeremy Rifkin, who is also a consultant to EU leaders on biotech issues,
explains why biotech companies are having such a difficult time in Europe:
What Monsanto lost sight of is that food is a deep statement of culture
in all the countries that make up Europe. The way people process and
prepare food is the story of who they are. In a world of globalization,
where people feel increasingly that they are losing control over so
many aspects of their lives, the one place they feel they still have some
control is the food they put on the table—and damned if they are going
to give that up for globalization.
William Greider, A High Level Food Fight, THE NATION, Nov. 3, 2003, at 16. Europe’s lack of
confidence seems to go hand-in-hand with the arrogance of the United State’s biotech
companies. McGarity, supra note 32, at 473. McGarity explains:
The U.S. biotechnology industry entered the GM food debates with an
arrogance reminiscent of the nuclear power industry in the 1950s.
Early in the highly contentious controversy in Europe over GM Foods,
a public relations specialist hired by an American biotechnology
company told critics that “people will have Roundup Ready soya,
whether they like it or not.” An executive for another American
company told the technical manager of a British supermarket chain
that he was a “backward European” who should “just accept that this
is right for your customers.” This arrogance backfired in Europe (the
supermarket chain made arrangements with Brazilian suppliers of
non-GM foods, as did many of its competitors), and by the late 1990s,
it was beginning to have a negative effect in the U.S. as well.
Id. (footnotes omitted).
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and 1996, consumers in Europe formed activist groups that protested the
new foods, and by fall of 1999, successfully convinced the UK and EU
regulatory agencies to place moratoriums on the growth of these
products and to stifle their import.83 Furthermore, Europeans appear to
be becoming less supportive of biotechnology in general.84 In contrast,
Kim Brooks, History, Change and Policy: Factors Leading to Current Opposition to Food
Biotechnology, 5 GEO. PUBLIC POL’Y REV. 153, 154 (2000) (proposing reasons why the United
Kingdom has so vehemently rejected GM foods). Consumer concern has also been
effective in convincing McDonald’s to not use beef from cows that have been fed with GM
foods in its Big Macs in Europe. Tom Carter, EU Aide Suggests Labeling Products; Officials
Disagree on Identifying Altered Foods, THE WASHINGTON TIMES, Oct. 19, 2003, at A09.
Furthermore, other large food producers, such as Heinz and Kraft, have stopped using GM
ingredients in the products they sell in Europe. Big Food Backtracks on Frankestein Projects,
MKTG. WK., Oct. 23, 2003, at 22. In Australia, George Weston Foods, Bakers Delight, Muffin
Break and Kellogg’s all have a GM-free policy, and Dairy Farmers, Domino’s Pizza,
Starbucks and the Cheesecake Shop are headed in that same direction. GM Foods: What
Consumers Want, SYDNEY MORNING HERALD, Sept. 12, 2003, at 14. Still, some attribute the
European resistance to GM products by officials to trade protectionism because of Europe’s
technological disadvantage. See Lawrence A. Kogan, Ducking the Truth About Europe’s
GMO Policy, INT’L HERALD TRIB., Nov. 27, 2004, at 6. The moratorium has effectively been
lifted as the European Commission has allowed the import of corn this past summer and
rape-seed this past winter. Jonathan Stearns, Monsanto Moves Closer to Winning EU Rapeseed
Approval, BLOOMBERG NEWS, Dec. 20, 2004, available at LEXIS, News Library, ALLBBN File.
84
Centre National De La Recherche Scientifique, Changes in European Attitudes Towards
Genetically Modified Organisms, available at http://www.cnrs.fr/cw/en/pres/compress/
ogm/ogmevolution.htm (last visited Jan. 4, 2005). The results from the Eurobaromter 2000
indicated that in 2000, 41% of people thought that biotechnology would improve our lives
over the next 20 years (down from 47% in 1997) and 23% thought that it would worsen our
lives (up from 19% in 1997). Id. The people who thought biotechnology would not affect
our lives in the next 20 years was 10% in 2000 (same as in 1997), and the number of people
who didn’t know was 26% in 2000 (up from 24% in 1997). Id.
This sentiment is fostered by information available to the people of Europe in
magazines and newspapers. A London based environmental journal, “The Ecologist,”
recently gave five reasons why Britain should be kept GM-free: GM will remove consumer
choice, health risks have not been disproved, farmers will be destroyed, the environment
will suffer, and GM crops will not feed the poor. Keep Britain GM-free, supra note 62, at 3439. Furthermore, a writer for THE ECOLOGIST criticized the UK government on its handling
of public opinion, suggesting in particular that the public debates offered by the
government were a sham, as is obviated by the fact that they lasted only a short time and
were finished before results of farm-scale trials were published. Andy Rowell, Debate, What
Debate?, THE ECOLOGIST, July/August 2003, at 30. These farm-scale trials, the results of
which came out in October of 2003, in fact showed that two out of three of the GM crops
tested may disadvantage wildlife.
Defra, Environmental Protection, available at
http://www.defra.gov.uk/environment/gm/fse/results/fse-summary.pdf (last visited
Jan. 4, 2005).
The newspaper, THE GUARDIAN, has also kept the public informed of the “dirty tricks
campaign” of one of the largest producers of GM foods, Monsanto. George Monbiot, The
Covert Biotech World: The Battle to Put a Corporate GM Padlock on Our Foodchain is Being
Fought on the Net, THE GUARDIAN, Nov. 19, 2002, at 19; George Monbiot, Corporate Phantoms:
The Web of Deceit Over GM Food Has Now Drawn in Tony Blair’s Speechwriters, THE
GUARDIAN, May 29, 2002, at 17; Zac Goldsmith, Environment in a Spin, THE GUARDIAN, May
83
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the attitude of Americans is more positive toward GM foods than in
Europe.85 People in the United States generally support agricultural
technology and are confident in the products and their regulation.86
However, both U.S. consumer support and paradoxically, opposition to
GM foods, seem to be decreasing.87 Still, many in the United States are
not in favor of GM foods; grassroots efforts have begun to lobby
Congress and the President to pass legislation that would require GM
foods in the United States to be labeled and more tightly regulated.88

16, 2002, at 19; George Monbiot, The Fake Persuaders: Corporations are Inventing People to
Rubbish Their Opponents on the Internet, THE GUARDIAN, May 14, 2002, at 15. These articles
describe how some computer gurus discovered that some unknown person using
computers at Monsanto or subsidiaries of Monsanto was creating fake citizens who were
allegedly activists in favor of biotechnology and were fiercely opposed to the critics of GM
foods. Id.
85
Magnuson & Hursti, supra note 82, at 9.
86
Biles, supra note 65, at 13.
87
The Mellman Group, The Pew Initiative on Food and Biotechnology, Sept. 15, 2003,
available at http://pewagbiotech.org/research/2003update/2003summary.pdf.
As of
August 2003, the numbers indicate that 25% of U.S. consumers polled supported the use of
GM foods (down 1% from 2001) and 48% opposed the use of GM foods (down 10% from
2001). Id.
88
See The Campaign to Label Genetically Modified Foods, at www.thecampaign.org
(last visited Jan. 4, 2005); Organic Consumers Association, Genetically Engineered Food, at
http://www.organicconsumers.org/gelink.html (last visited Jan. 4, 2005); Mothers for
Natural Law, at http://www.safe-food.org (last visited Jan. 4, 2005); see also Emily Marden,
Risk and Regulation: U.S. Regulatory Policy on Genetically Modified Food and Agriculture, 44
B.C. L. REV. 733, 753-56 (2003) (describing Mothers for Natural Law, Center for Food Safety,
Campaign to Label Genetically Engineered Foods, and the case Alliance for Bio-Integrity v.
Shalala). Many food products in the United States are currently void of GM materials due
to consumer concern, including the following: select Beech Nut baby foods, select Gerber
baby foods, select Heinz baby food, Bob’s Red Mill Pancake and Waffle Mixes, Alvarado
Street breads, French Meadow breads, Shiloh Farms breads, Health Valley granola bars and
cereals, Barbara’s Bakery cereals and cookies, and many more foods. See GreenPeace, True
Food Shopping List, available at http://www.truefoodnow.org/shoppersguide/guide_
printable.html (last visited Jan. 4, 2005).
Dr. Lawrence Busch argues that biotechnology has caused people to question several
assumptions: that all new technologies are beneficial, that the public will acquiesce, that
what is good for farmers is good for consumers, and that whatever is economically viable is
socially acceptable. Lawrence Busch, Assumptions About Biotechnology and Agriculture, 10
MICH. ST. U. DETROIT C. L. J. INT’L L. 57 (Spring 2001). Furthermore, Congressman Dennis
Kucinich drafted a series of bills addressing problems resulting from genetic engineering,
but which expired at the end of 2004: Genetically Engineered Food Right to Know Act, H.R.
2916, 108th Cong. (2003) (amending the FFDCA, the Federal Meat Inspection Act, and the
Poultry Products Inspection Act to mandate labeling of food that contains GM material or
was produced using GM material); Genetically Engineered Food Safety Act, H.R. 2917,
108th Cong. (2003) (amending the FFDCA regarding the safety of genetically engineered
foods); Genetically Engineered Crop and Animal Farmer Protection Act of 2003, H.R. 2918,
108th Cong. (2003) (ensuring fair dealing by biotech companies and protecting farmers and
ranchers from economic harm resulting from genetically engineered seed, plants, or
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Although Americans have a relatively more positive outlook on GM
foods, they are generally less informed on the issues surrounding GM
foods than are Europeans, and their knowledge is not necessarily
increasing.89
According to the Pew Initiative On Food and
Biotechnology (“Pew Initiative”), 58% of people polled said they had not
eaten GM foods.90 Yet, according to an estimate by the Grocery
Manufacturers of America, 70-80% of processed foods contain GM
ingredients.91 In January of 2001, the Pew Initiative revealed that 44% of
those polled had heard a “great deal” or “some” about GM foods,
compared with the August 2003 report where the percentage dropped
ten points to 34%.92 Moreover, Americans seem to be generally in favor
of government regulation of GM foods.93 Most Americans have faith in
the regulatory system in the United States concerning GM foods.94
However, again, most Americans have very little knowledge as to how
GM foods are regulated.95 Furthermore, regardless of Americans’
general faith in regulation, Americans clearly desire that GM foods be
labeled.96

animals); Genetically Engineered Organism Liability Act of 2003, H.R. 2919, 108th Cong.
(2003) (making biotech companies liable for injury resulting from the release of genetically
engineered organisms into the environment); Real Solutions to World Hunger Act of 2003,
H.R. 2920, 108th Cong. (2003) (ensuring that the use of genetically engineered animals and
crops to address world hunger issues will actually help developing countries); Genetically
Engineered Pharmaceutical and Industrial Crop Safety Act of 2003, H.R. 2921, 108th Cong.
(2003) (prohibiting the cultivation of genetically engineered pharmaceuticals in the open air
and creating a tracking system to regulate pharmaceutical and industrial crops).
89
See infra text accompanying notes 90-91 and notes 92, 95 and accompanying text.
90
The Mellman Group, supra note 87.
91
Id.
92
Id. Ipsos-Reid research supports the Mellman Group survey, indicating that in 2000
66% of Americans had heard of the issue, but only 4% felt they “kn[e]w a lot” about the
issue, and 15% say they have some understanding. Ipsos-Reid, Awareness of Genetically
Modified Foods Wide But Knowledge Inch Deep, June 8, 2000, available at
http://www.angusreid.com/pdf/media/mr000608_2ch.pdf.
93
The Mellman Group, supra note 87. The Pew research revealed that 89% of all people
surveyed agreed that any GM foods that reach the market should have to submit safety
data to the FDA. Id.
94
Id. According to the survey, 83% of consumers said they trusted what the FDA
concluded “a great deal” or “some.” Id.
95
Id. Only 44% of Americans have heard anything about how the government regulates
these foods, and only 9% said they knew a great deal about it. Id.
96
A 2001 telephone poll conducted by ABC News found that 93% of Americans believe
that the government should mandate labeling of GM foods. Gary Langer, Behind the Label,
ABC NEWS.COM, June 19, 2001, at http://abcnews.go.com/sections/scitech/DailyNews/
poll010619.html; The Center for Food Safety, Compilation and Analysis of Public Opinion Polls
on Genetically Engineered (GE) Foods, at http://www.centerforfoodsafety.org/new_nation.
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GM foods are innovative developments that could potentially benefit
humanity in many ways.97 However, GM foods come with risks and
raise ideological concerns.98 It is therefore unsurprising that, at the very
least, most consumers desire disclosure regarding these foods.99
However, in order for disclosure to be required, the government must
have proper authority to mandate such disclosure.100
B. Authority to Legislate Mandatory Labels
In order for Congress to create law, it must have the proper
authority. This authority involves a two-prong inquiry.101 The first
question is whether the Constitution has granted Congress authority to
create the particular legislation at issue.102 The second question is
whether the legislation at issue would violate another doctrine or
provision of the Constitution.103
Congress’s constitutional authority to mandate labeling of food
products is based on the Commerce Clause, through which Congress has
created the FFDCA.104 Congress has given the Food and Drug
Administration (“FDA”) the authority to mandate the labeling of food
products; however, the FDA has chosen not to use this authority to label
in the specific instance of GM food products.105 Therefore, if labeling of
cfm (last visited Jan. 4, 2005) (indicating that 88% of U.S. consumers want labels on GM
foods as of a 2002 poll).
97
See supra text accompanying notes 34-40.
98
See supra text accompanying notes 42-54.
99
See supra note 96 and accompanying text (describing how most Americans believe GM
foods should be labeled).
100
See infra Part II.B.
101
ERWIN CHEMERINSKY, CONSTITUTIONAL LAW 91 (2001); see also U.S. CONST. art. II, § 1,
cl. 8; U.S. CONST. amend. 10.
102
CHEMERINSKY, supra note 101, at 91.
103
Id.
104
U.S. CONST. art. I, § 8, cl. 3; Federal Food, Drug, and Cosmetic Act, Pub. L. No. 108-68,
52 Stat. 1040 (codified as amended in scattered sections of 21 U.S.C.); U.S. v. Walsh, 331 U.S.
432, 434 (1946).
105
Although the FDA does not mandate labeling of GM products, it has the statutory
authority to do so. McGarity, supra note 32, at 459-63. The FDA’s substantial equivalency
assumption directly impacts its decision that GM foods generally do not need to be labeled,
in that the FDA maintains that GM foods do not have any material changes that foods
derived from traditional breeding methods do not also have. For the text of 21 U.S.C.
§ 321(n), see infra note 151. In its 1992 Statement of Policy, the FDA says that “the new
techniques are extensions at the molecular level of traditional methods” and that “[t]he
agency is not aware of any information showing that foods derived by these new methods
differ from other foods in any meaningful or uniform way, or that, as a class, foods
developed by the new techniques present any different or greater safety concern than foods
developed by traditional plant breeding,” thus concluding that “the agency does not
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GM foods is to be mandated, Congress would need to be convinced of its
necessity and create legislation specifically requiring the FDA to
generate such rules.106 The main constitutional concern Congress would
encounter if it decided to mandate labeling of GM food products would
be that such legislation would violate the First Amendment, which
protects commercial speech.107

believe that the method of development of a new plant variety (including the use of new
techniques including recombinant DNA techniques) is normally material information
within the meaning of 21 U.S.C. 321(n) and would not usually be required to be disclosed
in labeling for food.” Statement of Policy: Foods Derived From New Plant Varieties, 57
Fed. Reg. 22984, 22991 (May 29, 1992) [hereinafter May 1992 Policy].
In a subsequent statement made in 2001 the FDA concluded that “[w]e are still not
aware of any data or other information that would form a basis for concluding that the fact
that a food or its ingredients was produced using bioengineering is a material fact that
must be disclosed under sections 403(a) and 201(n) of the act.” Draft Guidance for
Industry: Voluntary Labeling Indicating Whether Foods Have Not Been Developed Using
Bioengineering, 66 Fed. Reg. 4839, 4840 (Jan. 18, 2001) [hereinafter FDA, Draft Guidance].
However, if the FDA chose to do so, it clearly has authority to mandate the labeling of GM
foods. McGarity, supra note 32, at 459-63; Alicia T. Simpson, Note, Buying and Eating in the
Dark: Can the Food and Drug Administration Require Mandatory Labeling of Genetically
Engineered Foods? Alliance for Bio-Integrity, Et. Al. 116 F. Supp. 2d 166 (2000), 19 TEMP.
ENVTL. L. & TECH. J. 225 (2001) (concluding that the FDA currently has the authority to label
genetically engineered foods based on the application of the FDA’s “materiality test”).
For example, when considering whether irradiated food should be labeled, the FDA
was primarily concerned with what information the public thought was important.
McGarity, supra note 32, at 459. The FDA has not distinguished why it would not use this
same reasoning with GM foods in which the public is also concerned. Id. This ambiguity is
“very aggressive reliance on the substantial equivalence principle” and “effectively
deprives consumers, who are likewise unaware of practical methods to assess the
allergenic potential of such foods, of the option of playing it safe by avoiding such foods.”
Id. at 460. Furthermore, the decision in Alliance For Bio-Integrity allows, though does not
require, the FDA to mandate labeling if genetic modification results in any “uniform
changes” to food. Id. at 462. This opinion essentially allows for labeling of any GM food
because most GM plants are changed in some way by the GM process. Id. Instead, the
only mandatory labeling required by the FDA of GM foods is the same as that of other
foods; in 2001, the FDA made clear that special labeling is mandatory where absence of
material information poses health or environmental risks, misleads the consumer based on
statements made on the label, or misleads the consumer on the nutrition based on its
similarity to another food. FDA, Draft Guidance, supra, at 4840. Yet, the effects of
mandatory special labeling is minimal because the FDA still assumes that GM products are
GRAS. May 1992 Policy, supra, at 22988.
106
See infra Part III.A.
107
If the government were to force disclosure of GM foods, it is possible that companies
would not contest the regulation because of any negative attention they could receive.
However, it is just as possible that companies would challenge forced disclosure as the
Supreme Court has established that the First Amendment generally protects the right to
not speak. See, e.g., Wooley v. Maynard, 430 U.S. 705 (1977) (finding unconstitutional New
Hampshire’s enforcement of a statute prohibiting people from covering the motto “Live
Free or Die” on their license plates); Int’l Dairy Foods Ass’n v. Amestoy, 92 F.3d 67 (2d Cir.
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Commercial speech is generally protected by the First Amendment
under the theory that such speech promotes the free flow of information
to consumers, particularly regarding consumer concerns that are basic to
living.108 However, the Supreme Court recognizes that commercial
1996) (finding a Vermont statute requiring disclosure of the use of a GM hormone in milk
violated the First Amendment right to not speak); U.S. v. Frame, 885 F.2d 1119, 1132-33 (3d
Cir. 1989) (implicating the First Amendment, beef producers were required to help fund
commercial advertisement of which they did not necessarily subscribe). Furthermore, the
Court protects commercial speech, such as labels on products. See supra notes 108-22
(discussing compelled commercial speech).
108
Commercial speech has not always been protected. See Valentine v. Christensen, 316
U.S. 52, 54 (1942) (“[T]he Constitution imposes no restraint on government as respects
purely commercial advertising.”). However, the Supreme Court eventually recognized
that commercial speech is afforded protection under the First Amendment. See Bigelow v.
Virginia, 421 U.S. 809, 825 (1975) (concluding that the Virginia courts erred in assuming
that advertisements were not afforded any First Amendment protection).
The Supreme Court decided this protection of commercial speech was necessary so as
to allow the free flow of information to the public, especially regarding those things
essential to life. See Central Hudson Gas & Elec. Corp. v. Pub. Serv. Comm’n of New York,
447 U.S. 557 (1980). The Court said:
Commercial expression not only serves the economic interest of the
speaker, but also assists consumers and furthers the societal interest in
the fullest possible dissemination of information . . . . Even when
advertising communicates only an incomplete version of the relevant
facts, the First Amendment presumes that some accurate information
is better than no information at all.
Id. at 561-562; see also Zauderer v. Office of Disciplinary Counsel, 471 U.S. 626, 651 (1985)
(“[T]he extension of First Amendment protection to commercial speech is justified
principally by the value to consumers of the information such speech provides.”). Also, the
Court in Bolger v. Youngs Drug Products Corp. found that “[b]ecause the proscribed
information ‘may bear on one of the most important decisions’ parents have a right to
make, the restriction of ‘the free flow of truthful information’ constitutes a ‘basic’
constitutional defect regardless of the strength of the government’s interest.” 463 U.S. 60,
75 (1983) (citing Linmark Ass’n v. Willingboro, 431 U.S. 85, 95-96, 97 (1977)). In Linmark
Ass’n v. Willingboro the Court found that an ordinance prohibiting homeowners from
posting “For Sale,” for the purpose of preventing panic selling on the part of white
homeowners, was constitutionally defective because the prohibited advertising was of
“vital interest” to residents and would “bear on one of the most important decisions they
have a right to make: where to live and raise their families.” 431 U.S. 85, 96 (1977).
In order to properly analyze speech’s First Amendment protection from regulation, a
court must determine the status of the speech in question. See Bolger, 463 U.S. at 65
(“Because the degree of protection afforded by the First Amendment depends on whether
the activity sought to be regulated constitutes commercial or non-commercial speech, we
must first determine the proper classification of the mailings at issue here.”). If the Court
finds that the speech is compelled commercial speech but is intertwined with noncommercial speech, the Court will apply the standard used for fully protected speech and
thus the regulation will likely be considered content-based and struck down. See Riley v.
Nat’l Fed’n of the Blind, 487 U.S. 781, 795 (1988) (stating that “[m]andatory speech that a
speaker would not otherwise make necessarily alters the content of the speech” and is
therefore “content-based regulation of speech”). However, speech that is inherently
misleading is not afforded any protection at all. In re R.M.J., 455 U.S. 191, 203 (1982).

Produced by The Berkeley Electronic Press, 2005

Valparaiso University Law Review, Vol. 39, No. 4 [2005], Art. 8

1030 VALPARAISO UNIVERSITY LAW REVIEW

[Vol. 39

speech is fundamentally different from other kinds of speech because it
is motivated by profit, and therefore, the Court applies a less-than-strict
scrutiny to commercial speech.109 The Court developed the test for
commercial speech in Central Hudson Gas & Elec. Corp. v. Pub. Serv.
Comm’n of New York,110 under which courts must determine the
following: (1) whether the speech is concerning lawful activity and is
not misleading,111 (2) whether the government’s interest is substantial,112
Furthermore, although the government may altogether prohibit misleading advertising, it
“may not place an absolute prohibition on certain types of potentially misleading
information . . . if the information also may be presented in a way that is not deceptive.” In
re R.M.J., 455 U.S. at 203.
The Supreme Court in Bolger held that commercial speech encompasses more than just
an advertisement, a reference to specific products, and economic motivation. Bolger, 463
U.S. at 65, 66-67 (1983). However, the combination of all these factors indicates that the
speech is probably commercial speech. See Bolger, 463 U.S. at 66-67. Regarding
advertisement, although the Supreme Court has defined commercial speech as expression
that “propose[s] a commercial transaction,” Erwin Chemerinsky suggests that commercial
speech cannot just be advertisement because that would be both overinclusive (would
include some political speech) and underinclusive (would not include direct solicitation by
lawyers). CHEMERINSKY, supra note 101, at 1061.
Although the application of these criteria—whether it is an advertisement, a reference
to a specific product, and whether there is economic motivation—to labeling is not clear, in
Rubin v. Coors Brewing Co., both parties agreed that beer labels indicating alcohol content
are commercial speech. Rubin v. Coors Brewing Co., 514 U.S 476, 481 (1995). While not the
same as promoting a particular product or service, labels “may affect purchasers in
deciding whether to buy a particular product.” CHEMERINSKY, supra note 101, at 1066.
Therefore, if a label affords consumers more information regarding the product and seems
to affect whether or not consumers buy the particular product, it seems that the label
should be analyzed as commercial speech. See, e.g., Amestoy, 92 F.3d at 79-80 (Leval, J.,
dissenting) (describing why plaintiffs were erroneous in arguing that a sign informing
consumers of the use of a GM hormone in the production of milk was fully protected
speech).
109
Central Hudson, 447 U.S. at 562-564. Under this test, the burden for justifying a
regulation on commercial speech is on the party seeking to uphold the restriction.
Edenfield v. Fane, 507 U.S. 761, 770 (quoting Bolger v.Youngs Drug Products Corp., 463
U.S. 60, 71, n.20 (1983) and citing Board of Trustees of the State University of New York v.
Fox, 492 U.S. 469, 480 (1989)) (“It is well established that ‘the party seeking to uphold a
restriction on commercial speech carries the burden of justifying it.’”).
110
447 U.S. 557 (1980).
111
The First Amendment does not protect speech that concerns unlawful activity or
speech that is misleading. Central Hudson, 447 U.S. at 563-64. In Central Hudson, the Court
stated that “there can be no constitutional objection to the suppression of commercial
messages that do not accurately inform the public about lawful activity” so that “[t]he
government may ban forms of communication more likely to deceive the public than to
inform it . . . or commercial speech related to illegal activity . . . .” Id. The government may
also ban advertising that is true, but still misleading. See, e.g., Friedman v. Rogers, 440 U.S.
1 (1979) (upholding a state law that prohibited optometrists from practicing and
advertising under trade names because they offered no real information to the public but
could be very misleading by attracting the public to a name that was associated with a
particular optometrist but is no longer).
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(3) whether the regulation directly and significantly advances the
governmental interest asserted,113 and (4) whether the regulation is not
more extensive than is necessary to serve that interest.114
Furthermore, the Court’s approach to regulations that do not limit
speech but rather compel speech is different than the test articulated in
Central Hudson.115 According to Zauderer v. Office of Disciplinary
Counsel,116 although government restrictions on commercial speech may
infringe the First Amendment because they impede information flow to
consumers, government compulsion of commercial speech has just the
opposite effect, increasing information flow to consumers.117 The Court
held that although “unjustified or unduly burdensome disclosure
requirements might offend the First Amendment by chilling protected
commercial speech . . . an advertiser’s rights are adequately protected as
long as disclosure requirements are reasonably related to the State’s
interests in preventing deception of consumers.”118 In applying this
deferential standard, the Court in Zauderer upheld a state requirement
that an attorney advertising services on a contingent-fee basis must also
disclose to clients that they will still have to pay for costs even if their
case is not successful.119 Without this clarification, the advertising would

Central Hudson, 447 U.S. at 566.
Id. Justice Stevens added that the regulation must significantly advance the
government’s interest. 44 Liquormart, Inc. v. Rhode Island, 517 U.S. 484, 506 (1996).
114
Central Hudson, 447 U.S. at 566. The fourth prong of the test is less than clear. In Fox,
the Court explicitly said that a literal least restrictive means test was not necessary. Bd. of
Tr[s]. of State Univ. of New York v. Fox, 492 U.S. 469, 477 (1989). In 44 Liquormart, the
Court basically applied a reasonableness standard. 517 U.S. 484 at 507. However, in Rubin,
the Court again used the language found in Central Hudson and said that “a valid
restriction on commercial speech” is “no more extensive than necessary to serve [the
governmental] interest.” Rubin v. Coors Brewing Co., 514 U.S. 476, 486 (1995).
115
See supra notes 116-20 and accompanying text.
116
471 U.S. 626 (1985).
117
Compare supra note 108 and accompanying text (describing how commercial speech
has not always been protected, but the Supreme Court ultimately decided to protect it so as
to allow the free flow of information to consumers), with Zauderer, 471 U.S. 626. The Court
in Zauderer stated:
[C]onstitutionally protected interest in not providing any particular
factual information in . . . advertising is minimal. Thus, in virtually all
our commercial speech decisions to date, we have emphasized that
because disclosure requirements trench much more narrowly on an
advertiser’s interests than do flat prohibitions on speech, ‘warning[s]
or disclaimer[s] might be appropriately required . . . in order to
dissipate the possibility of consumer confusion or deception.’
Zauderer, 471 U.S. at 651 (citing to In re R.M.J., 455 U.S. 191, 201 (1985)).
118
Zauderer, 471 U.S. at 651.
119
Id. 652.
112
113
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be misleading and perhaps unprotected under the first prong of Central
Hudson.120
Although Zauderer has implications in cases where further
information is necessary to rectify incomplete, misleading commercial
speech, the Zauderer paradigm arguably does not fairly describe all
mandatory labeling of GM foods, especially unadvertised whole foods.121
Thus the more stringent Central Hudson test may be more appropriate,
which is the test used by the Second Circuit in Int’l Dairy Foods Ass’n v.
Amestoy.122
In Amestoy, dairy manufacturers challenged a Vermont statute
mandating labeling of milk containing the hormone rBST.123 The district
court denied the dairy manufacturers’ motion for a preliminary
injunction of the law, but the Second Circuit reversed, finding that the
manufacturers would likely have success on the merits because the
government did not have a substantial interest in requiring this
regulation, and thus, the law would fail the second part of the Central
Hudson test.124 To justify this holding, the court noted that the only
reason the government offered for mandating this labeling was
“consumer curiosity,” which the court said was not enough to overcome
the First Amendment right to not speak because there was no indication
of any real harm.125

See note 111 and accompanying text (discussing the first prong of Central Hudson).
Disclosure requirements are a less restrictive alternative to actual suppression on speech.121
See generally Int’l Dairy Foods Ass’n v. Amestoy, 92 F.3d 67 (2d Cir. 1996) (applying
Central Hudson, not Zauderer, to a statute requiring milk producers to disclose milk
containing the hormone rBST). But see infra note 277 (describing how even a generic
labeling such as “apple” is arguably misleading because most people would not assume
that the apple is a GM); see also supra notes 90-91 (showing that most people think they are
not eating GM food).
122
92 F.3d 67 (2d Cir. 1996).
123
Id.
124
Id. at 73-74. This holding effectively nullified the law; it was terminated March 30,
1998 pursuant to 1993, No. 127 (Adj. Sess.), § 4, as amended by 1997, No. 61, § 272i.
125
Amestoy, 92 F.3d at 73-74. Regarding the right to not speak, the Second Circuit relied
upon Wooley v. Maynard, 430 U.S. 705, 714 (1977) (“[T]he right of freedom of thought
protected by the First Amendment against state action includes both the right to speak
freely and the right to refrain from speaking at all.”). The Second Circuit also relied upon
West Virginia State Bd. v. Barnette, 319 U.S. 624, 633 (1943), and Harper & Row, Publishers, Inc.
v. Nation Entm’t., 471 U.S. 539, 559 (1985). To justify the necessity of real harm, the court
relied upon Edenfield v. Fane, 507 U.S. 761, 770-71 (1993) (“[A] governmental body seeking
to sustain a restriction on commercial speech must demonstrate that the harms it recites are
real and that its restriction will in fact alleviate them to a material degree.”).
120
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However, Judge Leval, in a dissenting opinion, found several flaws
with the majority’s reasoning.126 First, he said that the court ignored
evidence of the important governmental purposes for such labeling,
which extended beyond just consumer curiosity to include consumer
concerns regarding possible adverse health affects, health risks to cows,
the economic impact on small dairy farmers from the increase in milk
production, and philosophical objections to biotechnology made by the
public.127 Second, Judge Leval said that the majority took out of context
the assertion made by the district court that the basis of passing the law
was not health-related.128 He explained that the context of the district
court’s statement indicated that the district court meant that because the
state does not know what harm may be caused by rBST, the consumers’
interest to know is not just based on curiosity, but rather is a real healthrelated concern.129 Third, Judge Leval determined the majority was
dangerous in suggesting that any concerns people may have regarding
the health risks of rBST must not be real since the FDA has thus far
found no health risks.130 He noted that the biotechnological techniques
used to make rBST are new and controversial, and although the FDA has
done “thorough” testing on rBST, the testing has not been performed on
a long-term basis and arguably not as thoroughly as necessary based on
inadequate amounts of time, money, and scientific advancement.131
Citing Zauderer, Judge Leval also pointed out that the purpose of
protecting commercial speech is to increase disclosure, and that in this
case, the manufacturers are “invok[ing] the Amendment’s protection to
accomplish exactly what the Amendment opposes.”132
Amestoy raises the First Amendment objection a statute requiring
labeling of GM products would likely face. Furthermore, the split
between the majority and dissent in Amestoy parallels the differing
approaches toward GM food taken by the governing forces in Europe
and the United States.133 The reasoning behind a government’s
Amestoy, 92 F.3d at 76-78 (Leval, J., dissenting).
Id. at 78.
128
Id. at 76. The statement the majority took from the district court is that the state “does
not claim that health or safety concerns prompted the passage of the Vermont Labeling
Law,” but rather “bases its justification . . . on strong consumer interest and the public’s
‘right to know.’” Id.
129
Id.
130
Id.
131
Id. at 76-77. Judge Leval also noted that “[f]orty years ago, when I (and nearly
everyone) smoked, no one told us that we might be endangering our heath.” Id. at 77.
132
Id. at 81; supra note 108 and accompanying text (discussing the Court’s purpose for
extending First Amendment protection to commercial speech).
133
See infra Part II.D.1.
126
127
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mandatory or permissive product labeling further clarifies the
distinction between these differing approaches towards GM food.134
C. Reasons for Labeling
Essentially, products are either labeled because the government
forces a company to do so or because a company volunteers the
information.135 Governments may force companies to label for various
reasons, but to do so, the government, at least in the United States, must
have statutory authority and be consistent with the First Amendment.136
Furthermore, the government may have to regulate voluntary labeling in
order to avoid misleading commercial information.137
1.

Mandatory Labeling

Because markets never work as flawlessly as theory would suggest
and never account for all of the concerns of humanity and society,
government regulation of markets is sometimes necessary.138 More
specifically, the two main reasons governments regulate product
labeling are to increase efficient information dissemination and to
promote consumer protection.139
Governments may require companies to label their products in order
to decrease the transactional costs involved with gathering
information.140 Businesses, and people in general, gather and rely upon
information every day in order to make educated and resourceful
purchasing decisions.141 The economy is less productive if consumers
have to bear all of the time and expense of gathering information.142
See infra Part II.C.
See infra Parts II.C.1, II.C.2.
136
See infra notes 140-54 and accompanying text.
137
See infra notes 155-59 and accompanying text.
138
See JEFFREY L. HARRISON ET AL., REGULATION AND DEREGULATION: CASES AND
MATERIALS 25-26 (West Publishing Co. 1997). See also generally JOSEPH E. STIGLITZ, THE
ROARING NINETIES (2003) (explaining the relationship between government regulation in
the United States and market behavior through the end of the twentieth century).
139
See infra notes 140-47 and accompanying text.
140
HARRISON ET AL., supra note 138, at 210.
141
See, e.g., BizRate.com Comparison Shopping, at http://www.bizrate.com (last visited
Jan. 10, 2005).
142
This inefficiency is evidenced by the fact that there are companies that collect and
organize information that they sell to others. See, e.g., Dublin Metadata Core Initiative, at
http://dublincore.org (last visited Jan. 5, 2005). Dublin Metadata Core Initiative is an
online company whose purpose is to categorize information by creating a “core set of
semantics for Web-based resources” in order that information may be more readily
retrievable. Id. at http://dublincore.org/about/history/ (last visited Jan. 5, 2005).
134
135
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Therefore, it is in the government’s best interest for information
dissemination within the market to be as cost efficient as possible. 143 In
order to lower the transactional cost of information gathering, the
government has implemented regulations that place a degree of the duty
to gather and disclose information on sellers and service providers.144
The second reason that governments regulate product labeling is to
promote health, safety, and other consumer interests.145 In situations
where a product is questionable, rather than directly regulating the
product, the government may require that companies label the product
to disclose the potential danger, detriment, or concern.146 This
requirement not only informs the public of the potential problem, but
also results in public pressure on companies to improve quality and
safety.147
A recent example of the government mandating disclosure of
information to the public regarding products is a final rule promulgated
by the FDA on July 11, 2003.148 This final rule states that as of January 1,
2006, trans fatty acids must be included on the nutritional label of foods
so that consumers are better able to avoid ingesting too much of this
HARRISON ET AL., supra note 138, at 210. Transactional costs are all the factors
involved in actually making a transaction happen, including time spent negotiating, money
spent in developing a product or idea and any other necessary efforts. Id. at 28-29.
144
Id. For example, car dealers are required to report expected gas miles of new vehicles,
and many professionals are required to get certified or licensed. Id. at 29.
145
See, e.g., infra text accompanying notes 148-54 (discussing the FDA mandating labeling
of trans fatty acids); see also Diane Thue-Vasquez, Genetic Engineering and Food Labeling: A
Continuing Controversy, 10 SAN JOAQUIN AGRIC. L. REV. 77 (2000). For example, in the case
of protein hydrosylates, the FDA mandated labeling based on possible religious or moral
conflicts with consumption of milk-derived protein. Id. at 90; Food Labeling; Declaration of
Ingredients, 56 Fed. Reg. 28592, 28,599 (proposed June 21, 1991) (to be codified at 21 C.F.R.
pts. 101, 130, 131, 133, 135, 136, 137, 139, 145, 146, 150, 152, 155, 156, 158, 160, 161, 163, 164,
166, 168, and 169). Furthermore, in regards to labeling irradiated foods, the FDA said that
“[w]hether information is material . . . depends not on the abstract worth of the information
but on whether consumers view such information as important and whether the omission
of label information may mislead a consumer.” Food Labeling; Foods Derived From New
Plant Varieties, 58 Fed. Reg. 25,837, 25,838 (Apr. 28, 1993) [hereinafter Foods From New
Plants].
146
See generally Seema Arora & Timothy N. Cason, An Experiment in Voluntary
Environmental Regulation: Participation EPA’s 33/50 Program, 28 J. ENVTL. ECON. & MGMT. 271
(1995) (discussing an approach the EPA used to decrease industrial release of toxic
substances through pressure created by increasing public awareness).
147
See generally id. (discussing an approach the EPA used to decrease industrial release of
toxic substances through pressure created by increasing public awareness).
148
Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and
Health Claims, 68 Fed. Reg. 133, 414334, 41434, 41436 (July 11, 2003) (to be codified at 21
C.F.R. pt. 101) [hereinafter Labeling Trans Fatty Acids].
143
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particular type of fat, as research suggests that trans fatty acids increase
the risk of coronary heart disease.149 In the commentary to its rule, the
FDA addressed its statutory authority for making changes to the labeling
requirements.150 The FDA cited several statutes from the FFDCA and
concluded that food labels not including information regarding trans
fatty acids are misleading and misbranded and thus violate the Act.151 In
response to comments that this rule would violate the First Amendment,
the FDA maintained that it is necessary that trans fatty acids be
disclosed.152 To not disclose this information would omit a material fact
regarding the nutrition of a product, which would be misleading to
consumers, whose assumption is that the nutritional label contains all of
the information necessary to make decisions regarding the effect of the
food on their health.153 Thus, the FDA’s rule requiring disclosure of trans
fatty acids in food is an example of the government mandating labeling
for the overall benefit of consumers; however, there are many instances
in which companies are motivated to provide this type of information
voluntarily.154

Labeling Trans Fatty Acids, 68 Fed. Reg. at 41434, 41436.
Id. at 41437-38.
151
Id. Both 21 U.S.C. § 371(a) (2000) and 21 U.S.C. § 343(q)(2) (2000) vest general
authority to the Secretary to enforce the act. 21 U.S.C. § 321(n), which helps define whether
a label is false or misleading, provides:
If an article is alleged to be misbranded because the labeling or
advertising is misleading, then in determining whether the labeling or
advertising is misleading there shall be taken into account (among
other things) not only representations made or suggested by statement,
word, design, device, or any combination thereof, but also the extent to
which the labeling or advertising fails to reveal facts material in the
light of such representations or material with respect to consequences
which may result from the use of the articles to which the labeling or
advertising relates under the conditions of use prescribed in the
labeling or advertising thereof or under such conditions of use as are
customary or usual.
21 U.S.C. § 321(n)(2000). The FDA concluded that because trans fat in foods may increase
or decrease the consumer risk of developing Coronary Heart Disease, information
regarding trans fat in food is material. Labeling Trans Fatty Acids, 68 Fed. Reg. at 41438.
152
Id. at 41439.
153
Id. One comment suggested that the cost of labeling to the companies may be an
unjustified burden upon which the First Amendment imposes limitations because the rule
does not “materially alleviate a genuine harm of potential consumer deception.” Id. The
FDA maintained that the omission of information on trans fatty acids would likely mislead
consumers because the reasonable consumer would expect the FDA to provide this
information. Id. This First Amendment conclusion by the FDA supports Judge Leval’s
dissenting opinion in Amestory. See supra text accompanying notes 126-32.
154
See infra Part II.C.2.
149
150
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Voluntary Labeling

There are several reasons companies voluntarily give consumers
information regarding their products.155
One reason companies
voluntarily label is to avoid tort liability by warning people of potential
dangers or instructing them of the proper and improper uses of a
product.156 Another reason companies provide additional information is
to promote features of their products that are attractive to some or all of
their buyers.157 This additional voluntary information can potentially be
misleading, or at least ambiguously favorable to a company’s interests or
unfavorable to other companies’ interests, and can result in unfair
business practice.158 Thus, the government not only compels information
disclosure through regulation, but also regulates, to some extent,
information that is voluntarily offered by companies.159

See infra notes 156-59 and accompanying text.
See VINCENT R. JOHNSON & ALAN GUNN, STUDIES IN AMERICAN TORT LAW 688-92 (2d
ed. 1999) (discussing several liability issues related to a company’s failure to warn of any
dangers related to its products).
157
For example, products may be labeled Kosher, environmentally friendly, non-toxic,
organic, low-carb, sugar-free, fortified, or made of recycled paper. See My Kosher
Food.com, at http://www.mykoshermarket.com (last visited Jan. 5, 2005); Printable
Promotions, at http://www.printablepromotions.com/Articles/Green.htm (last visited
Jan. 5, 2005) (promoting “Environmentally Friendly Promotional Products”); Safe 2 Use, at
http://www.safe2use.com (last visited Jan. 5, 2005) (promoting environmentally and
people-safe products including non-toxic products); Organics, at http://www.oraganic.
com/ (last visited Jan. 5, 2005) (selling only certified organic products); Holsum, at
http://www.holsumaz.com/breads-low-carb-buns.php (last visited Jan. 5, 2005)
(advertising low carb buns); Candy Warehouse, at http://www.candywarehouse.com/
sugarfreecandy.html (last visited Jan. 5, 2005) (advertising sugar free candy, but with the
following disclaimer: “Consumption of sugar-free products may cause mild laxative
effects. We recommend starting with a small serving size.”); Fortified Products.com, at
http://www.fortifiedproducts.com/fp_about.html (last visited Jan. 5, 2005) (stating that it
is “in the business of fortifying and modifying different foods”); Treecycle Recycled Paper,
at http://www.treecycle.com (last visited Jan. 5, 2005) (using the term “post-consumer
waste” so often that they posted a notice that they would instead use the acronym “PCW”
throughout their website).
158
See, e.g., Ass’n of Nat’l Advertisers, Inc. v. Lungren, 44 F.3d 726 (9th Cir. 1994). The
Ninth Circuit upheld a statute regulating different environmental labeling terms such as
“biodegradable” and “recyclable,” finding that the statute met the Central Hudson test
because these terms had been used differently within the industry, creating confusion and
the opportunity for abusive practices by businesses. Id. at 727-28, 737; supra notes 108-14
and accompanying text (regarding the Central Hudson test).
159
The extent to which the government should be allowed to regulate labeling in general
is not without debate. See James O’Reilly & Amy Dalal, Off-Label or Out of Bounds? Prescriber
and Marketer Liability for Unapproved Uses of FDA-Approved Drugs, 12 ANN. HEALTH L. 295,
297 (discussing the challenges the FDA faces in regulating off-label drugs as it tries to
155
156

Produced by The Berkeley Electronic Press, 2005

Valparaiso University Law Review, Vol. 39, No. 4 [2005], Art. 8

1038 VALPARAISO UNIVERSITY LAW REVIEW

[Vol. 39

D. Legal Issues Concerning Labeling GM Foods
The two major legal concerns regarding GM food labeling are
whether labeling can be mandated and what types of voluntary labeling
of GM foods can be allowed without being misleading.160 On a global
scale, the WTO is currently addressing whether labels on GM foods can
be mandated.161 Within the United States, the FDA has addressed how
companies should label GM or non-GM foods in order to not mislead the
public, and there has been at least one lawsuit regarding whether
volunteered information on labels is indeed misleading.162
1.

WTO Dispute and Mandatory Labeling

On August 8, 2003, the United States, together with Canada and
Argentina, requested that the WTO establish a panel to address a matter
entitled “European Communities—Measures Affecting the Approval
and Marketing of Biotech Products.”163 The United States was concerned
with a moratorium the European Communities had placed on the
approval of agricultural biotechnology products in October of 1998.164
This moratorium resulted in severe European restrictions of agricultural
and food imports from the United States.165
In early July 2003, the European Parliament, in an attempt to bring
an end to the moratorium, approved regulations to set up strict labeling

balance the desires of special interest groups that more information be disclosed with the
desires of drug marketers to be free from regulation).
160
See infra Parts II.D.1, II.D.2.
161
See infra Part II.D.1.
162
See infra Part II.D.2.
163
European Communities—Measures Affecting the Approval and Marketing of Biotech
Products—Request for the Establishment of a Panel by the U.S., WT/DS291/23 (Aug. 8, 2003)
[hereinafter EC – Request for Panel]. The United States first brought this issue to the WTO
on May 13, 2003 by requesting consultations on the issue. European Communities—Measures
Affecting the Approval and Marketing of Biotech Products – Request for Consultations by the
United States, WT/DS291/1 (May 20, 2003) [hereinafter EC—Request for Consultations].
Several other interested nations attended these consultations including Peru, Colombia,
Mexico, Argentina, New Zealand, Australia, India, Canada, Brazil, and Chile. European
Communities—Measures Affecting the Approval and Marketing of Biotech Products—Acceptance
by the European Communities of the Requests to Join Consultations, WT/DS291/22 (June 19,
2003). The consultations failed to resolve anything, and the United States decided to go
forward with filing a formal complaint with the WTO. Reuters, U.S. to Seek WTO Ruling on
Biotech Goods Ban, LOS ANGELES TIMES, June 20, 2003, at 4.
164
EC—Request for Consultation, WT/DS291/1 (May 20, 2003). This moratorium was
primarily the result of public pressure. See supra note 83 and accompanying text.
165
EC—Request for Consultations, WT/DS291/1 (May 20, 2003).
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standards for GM foods.166 The United States found that this attempt by
the European Parliament did not alleviate the violation of trade
agreements, and thus, went forward in requesting a WTO panel to
address the issue.167 The European Communities responded that its new
rules were in full compliance with WTO rules.168
The United States alleges that the European Union is violating WTO
law in three ways: by suspending consideration for application and
granting of biotech imports, by blocking applications already in the
approval process from final approval, and by allowing member states to
ban or restrict national marketing and importation of biotech products.169
The United States says that the European Union is violating the
Agreement on Technical Barriers to Trade,170 which does not allow for
technical regulations to create unwarranted trade barriers.171
Furthermore, the United States argues the European Union is violating
the Sanitary and Phytosanitary Measures,172 which requires:
[Members of the WTO only take] measures to protect
human life or health if based on scientific principles,
and, if scientific information is not available, a member
may adopt measures provisionally but must seek
additional information within a reasonable time.173
Because the United States believes that it has already given the
European Union a reasonable amount of time to seek additional
information, the debate now comes down to current scientific
166
John Rega, EU Parliament Votes to Label More Gene-Altered Food, BLOOMBERG NEWS, July
2, 2003, available at LEXIS, News Library, ALLBBN File.
167
EC – Request for Panel, WT/DS291/23 (Aug. 8, 2003); see also Rega, supra note 166. Bob
Stallman, who is the head of the American Farm Bureau Federation, said of EU’s new
labeling laws, “It’s commercially impossible to comply with the rule, it’s not justified by
any scientific analysis and it’s just as WTO-inconsistent as the biotech ban that the EU says
it will replace.” Rega, supra note 166.
168
Dave Williams, EU Rejects US Trade Suit Over GM Food, MORNING STAR, Aug. 9, 2003,
at 4. European commission spokeswoman Beate Gminder said: “We very much regret this
decision . . . we think that our system of GMO authorisation is clear, transparent and nondiscriminatory and complies with WTO rules.” Id.
169
EC—Request for Consultations, WT/DS291/1 (May 20, 2003).
170
Agreement on Technical Barriers to Trade, Apr. 12, 1979, 31 U.S.T. 405.
171
See Stuart S. Malawer, Put Down the Genetically Modified Tomatoes: It’s No Time to Pick a
Trade Fight over Biotech Foods, LEGAL TIMES, Sept. 1, 2003, at 44.
172
Agreement on the Application of Sanitary and Phytosanitary Measures [hereinafter
SPM Agreement], Apr. 15, 1994, arts. II and V (basic rights and obligations and assessment
of risk).
173
Id.; see also Malawer, supra note 171, at 44 (explaining the basic contentions by the
United States against the EU, and why this is a bad time to create a dispute).
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information.174 The international standard for determining the scientific
validity of restrictions created by the European Union is the consistency
of the restrictions with the standards suggested by the Codex
Alimentarius Commission (“Codex”).175
The Codex has recently
adopted risk assessment guidelines that include pre-market safety
evaluations as well as systems that can trace foods, neither of which the
United States currently implements.176
Stuart S. Malawer, the
Distinguished Service Professor of Law & International Trade at George
Mason University’s School of Public Policy, suggests that, based on the
Codex as well as a number of other factors, the outcome does not look
promising for the United States. 177 Still, the United States says that it has
no choice but to take the case to the WTO, concluding that the trade
barrier was still intact with these new rules.178 Despite the fact that the
European Commission has effectively lifted the ban, the United States
has not withdrawn its dispute from the WTO.179

174
U.S. Agriculture Secretary Ann Veneman said, “We have been extremely patient with
the Europeans for almost five years . . . . We have had exhaustive discussions with the
Europeans and it is now time to let the dispute settlement process work.” David Clarke,
Bush Cranks Up Efforts, THE JOURNAL (Newcastle, U.K.), Aug. 11, 2003, at 1.
175
Malawer, supra note 171. The Codex is an international organization created in 1963
by the Food and Agriculture Organization and the World Health Organization. Id.; see also
SPM Agreement, art V.
176
Malawer, supra note 171; Codex Alimentarius, Current Official Standards, at
http://www.codexalimentarius.net/web/standard_list.do?lang=en (last visited Jan. 5,
2005) (providing the Principles for the Risk Analysis of Foods Derived from Modern
Biotechnology, Guideline for the Conduct of Food Safety Assessment of Foods Derived
from Recombinant-DNA Plants, and Guideline for the Conduct of Food Safety Assessment
of Foods Produced Using Recombiant-DNA Microorganisms, in reference numbers
CAC/GL 44, CAC/GL 45, and CAC/GL 46 respectively).
177
Malawer, supra note 171. Other factors that Malawer pointed out that favor the EU
are the labeling requirements that would allow for importation of these foods, the EU’s
2002 regulatory framework, which the EU claims is based on scientific evidence, and the
suit brought by the EU against eleven member states in July. Id.; Sara Lewis, Failure to
Apply Biotech Rules Lands 11 Member-States in Court, FOOD CHEMICAL NEWS, July 28, 2003, at
1 (describing how the European Commission brought 11 member states to court for not
adopting legislation regarding the deliberate release of bioengineered crops); see also infra
note 179 and accompanying text (describing how the European Commission has already
effectively lifted the ban).
178
Clarke, supra note 174. The U.S. Trade Representative Robert Zoellick said that “[t]his
trade barrier harms farmers and consumers around the world by denying them the benefits
of productive, nutritious and environmentally friendly biotech products.” Id.
179
Jonathan Stearns, Monsanto Moves Closer to Winning EU Rapeseed Approval, BLOOMBERG
NEWS, Dec. 20, 2004, available at LEXIS, News Library, ALLBBN File (describing how the
moratorium has effectively been lifted as the European Commission has allowed the
import of corn this past summer and rape-seed this winter). On November 2, 2004, the
WTO postponed the estimated time for issuing final reports on the dispute until June of
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The root of the problem between the United States and the European
Union regarding GM foods and products is that the approach each takes
to regulating such foods is dramatically different.180 The approach taken
by the United States is very lenient towards manufacturers of such foods
so as to encourage scientific development, whereas the approach taken
by the European Union is one of caution and suspect.181
The current regulatory scheme in the United States on GM foods, or
more generally, for biotechnological research and products, is called the
“Coordinated Framework for Regulation of Biotechnology.”182 Under
this scheme, three agencies regulate biotechnology: the U.S. Department
of Agriculture (“USDA”), the Environmental Protection Agency
(“EPA”), and the FDA.183 Generally, the role of the USDA is to regulate
biotech plants.184 However, if biotech plants produce pesticides, the EPA
has primary control.185 And not surprisingly, the FDA regulates food
produced by GM plants.186 Finally, producers of GM plants and foods
retain an element of self-regulation.187

2005. European Communities—Measures Affecting the Approval and Marketing of Biotech
Products – Communications from the Chairman of the Panel, WT/DS291/27 (Nov. 2, 2004).
180
See generally Nathan W. Eckley, Reaping the Benefits of Agricultural Biotechnology
Through Uniform Regulation, 35 J. MARSHALL L. REV. 433, 443-51 (2002) (describing how the
regulatory systems of the United States and the EU are “out of tune” and suggesting a
comprised “Hybrid International Regulatory System”).
181
Id. Compare infra text accompanying notes 187-203, with infra text accompanying notes
204-220.
182
Coordinated Framework for Regulation of Biotechnology, 51 Fed. Reg. 23,302 (June
26, 1986).
183
See generally Rebecca M. Braspies, Consuming (F)ears of Corn: Public Health and
BioPharming, 30 AM. J. L. & MED. 371 (2004) (describing the current regulatory system for
biopharming, concluding it is inadequate, and offering corrective changes to it). See also
Marden, supra note 88, at 745-87 (describing the current administrative implementation of
the policy for GM technology); Stanley H. Abramson & J. Thomas Carrato, Crop
Biotechnology: The Case for Product Stewardship, 20 VA. ENVTL. L. J. 241, 245 (2001) (reviewing
the government’s oversight program of plant biotechnology).
184
Abramson & Carrato, supra note 183, at 247 (describing the regulation of plants by the
USDA and in particular by the Animal and Plant Health Inspection Service under the Plant
Protection Act).
185
Id. at 253-55 (describing the regulation of “pesticide-plants” by the EPA under the
Federal Insecticide, Fungicide, and Rodenticide Act).
186
Id. at 249-53 (describing the regulation of food by the FDA under the Food, Drug, and
Cosmetic Act).
187
See id. at 259-66 (describing the role of “product stewardship” in the regulation of the
plant technology); infra note 194 and accompanying text (describing how the FDA allows
companies to determine whether a product is GRAS or not). When the biotech leader,
Monsanto, was first introducing its new GM science, it requested Vice President George
Bush to regulate it so as to improve public trust. Eichenwald, supra note 82. That
administration, as well as the two that followed it, made sure that Monsanto, a company
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The authority for regulation of GM foods by the FDA, the agency
most directly responsible for labeling foods, is governed by the
FFDCA,188 under which the FDA regulates “adulterated foods.”189 More
specifically, the FDA asserts its power to regulate GM foods based upon
its authority to regulate food additives.190 The FDA characterizes many
food additives as being “generally recognized as safe” (“GRAS”), in
which case they are not subjected to formal review in order to be
marketed.191 The FDA’s policy toward GM foods assumes substantial
equivalency, and so essentially holds the position that there is no
distinction between food resulting from genetic modification by
conventional breeding and that done by genetic engineering.192 Either
way, the FDA assumes that the insertion of genetic material is GRAS.193
Although the FDA encourages companies producing new foods to
consult the FDA if it has a question regarding a new food’s status,

with deep ties to Washington, got exactly the regulation that it wanted: “If the company’s
strategy demanded regulations, rules favored by the industry were adopted. And when
the company abruptly decided that it needed to throw off the regulations and speed its
foods to market, the White House quickly ushered through an unusually generous policy
of self-policing.” Id.
188
Federal Food, Drug, and Cosmetic Act, Pub. L. No. 75-717, 52 Stat. 1040 (codified as
amended in scattered sections of 21 U.S.C.).
189
McGarity, supra note 32, at 434. Adulterated foods include foods in which “any
valuable constituent has been in whole or in part omitted or abstracted therefrom” and
foods in which “any substance has been substituted wholly or in part therefor.” 21 U.S.C.
§ 342(b)(1)-(2)(2000).
190
McGarity, supra note 32, at 436-37; see also 21 U.S.C. § 348(a)(2)(2000).
191
May 1992 Policy, supra note 105, at 22989. Cynthia D. Fisher suggests that when the
FDA grants the GRAS exception, it violates the Due Process Clause of the Fourteenth
Amendment by taking away the general public’s right to know exactly what is in our food,
a right that has been developed through a series of cases that establish personal autonomy
of certain decisions regarding family, self, and private interests. Cynthia D. Fisher, Note
and Comment, The Genie Is out of the Bottle: Consumers Demand Mandatory Labeling on
Genetically Engineered Foods, 4 J. LEGAL ADVOC. & PRAC. 88, 116-119 (2002).
192
May 1992 Policy, supra note 105, at 22985 (“In most cases, the substances expected to
become components of food as a result of genetic modification of a plant will be the same
as or substantially similar to substances commonly found in food.”); see supra notes 77-80
and accompanying text (discussing substantial equivalency); supra note 105 (stating that the
FDA’s substantial equivalency assumption directly impacts its decision that GM foods
generally do not need to be labeled).
193
McGarity, supra note 32, at 440; see also May 1992 Policy, supra note 105, at 22988.
Cynthia D. Fisher argues that genetic engineering is not just an extension of conventional
breeding because traditionally the only organisms that have been crossed have been done
naturally, whereas “genetic engineering ignores nature’s fundamental safeguard against
genetic uniformity . . . .” Fisher, supra note 191, at 91-92 (emphasis original).
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companies ultimately decide themselves whether an additive is GRAS
before the food goes to market.194
In 2000, in Alliance For Bio-Integrity v. Shalala,195 over twenty scientists
and religious leaders questioned the assumption by the FDA as depicted
in its 1992 statement that transgenes are presumed to be GRAS.196 Not
allowing into the record any scientific documentation made after the
1992 statement regarding whether transgenes should be considered
GRAS, the D.C. Circuit Court found that the FDA’s GRAS assumption
was not inconsistent with the statutory requirements of the FFDCA.197
Following this decision, the FDA decided to hold public hearings to
revisit the 1992 policy, after which it issued a new statement in which it
proposed mandatory pre-market notification on the part of
manufacturers.198 At the present time, however, the 1992 policy is still in
effect.199
The approach taken by the European Union and its member states is
very different from that of the United States.200 The major assumption of
the European Union regarding GM foods could be described as the
“precautionary principle,” which basically maintains that “pro-active
measures must be taken to reduce the risk of uncertain scientific

194
May 1992 Policy, supra note 105, at 22989 ([T]he “FDA has traditionally encouraged
producers of new food ingredients to consult with FDA when there is a question about an
ingredient’s regulatory status . . . even though such consultation is not legally required.”).
The goal of the most recent draft guidance released by the FDA on biotech food safety is
simply to provide an optional scientific framework for evaluating the safety of new
proteins in food early in the process. See generally Draft Guidance for Industry:
Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins
Produced by New Plant Varieties Intended for Food Use, 69 Fed. Reg. 68381 (Nov. 24,
2004).
195
116 F. Supp. 2d 166 (D.D.C. 2000).
196
Id.; Alliance for Bio-Integrity, Landmark Lawsuit Challenges FDA Policy on Genetically
Engineered Food, at http://www.bio-integrity.org/Lawsuit.html (last visited Jan. 5, 2005).
197
Alliance For Bio-Integrity, 116 F. Supp. 2d at 177-78. The court also found that the FDA
was not required to label under the statute, nor was the 1992 statement by the FDA a
violation of the Religious Freedom Restoration Act or free exercise of religion. Id. at 178-81.
198
McGarity, supra note 32, at 440; see also FDA, Draft Guidance, supra note 105; Christine
Cochran, Note, Premarket Notice Concerning Bioengineered Foods: A Proposed Regulation
Satisfying Some of the Players, Some of the Time, 12 WASH. U. J.L. & POL’Y 173 (2003)
(discussing the proposal by the FDA and useful changes to it).
199
McGarity, supra note 32, at 441. As soon as the George W. Bush administration took
over, Chief of Staff Andrew H. Card wrote a memo asking agencies to withdraw all
proposed and final regulations not yet published, but the 1992 proposed policy regulations
had already been published, and presumably will still be reviewed. Id.
200
See Eckley, supra note 180.
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dangers.”201 Based on this assumption, the risk assessment conducted by
the European Union on GM foods is very thorough and the regulation is
extensive.202
The European Union’s GMO legal framework has four main legal
instruments, which regulate work on genetically modified
microorganisms in closed environments, release of GMOs into the
environment and placement on the market, the placing of GMO food or
feed on the market, and the movement of GMOs between EU member
states and third countries.203 One of these legal instruments, Directive
201
Eckley, supra note 180, at 443. The precautionary principle is defined many ways
along a continuum, where on the one end the term is defined in such a way that its impact
is weak, so that anyone would accept it, and on the other end the term is defined so that the
impact is strong, possibly requiring fundamental changes in regulation. Cass R. Sunstein,
Beyond the Precautionary Principle, 151 U. PA. L. REV. 1003, 1011-12 (2003). Oftentimes
Europe is seen as much more precautionary than the United States; however, there are
many areas in which the United States is very precautionary “including particulate air
pollution, mad cow disease in blood, youth violence, and terrorism.” Jonathan B. Weiner,
Whose Precaution After All? A Comment on the Comparisons and Evolution of Risk Regulation
Systems, 13 Duke J. Comp. & Int’l L. 207, 209 (2003). Cass R. Sunstein argues that the
precautionary principle should be abandoned altogether, “not because it leads to bad
directions, but because, read for all that it is worth, it leads in no direction at all.” Sunstein,
supra, at 1004.
202
See infra notes 203-14 and accompanying text (describing the extensive regulatory
scheme of the EU); see also Annex II of European Parliament and Council Directive
2001/18/EC, 2001 O.J. (L106/1), available at Westlaw at OJ 2001 L106/1 (describing the
step-by-step risk assessment process to be conducted on GMOs: (1) identify any
characteristics of GMOs that may have adverse affects, (2) evaluate potential consequences
of those adverse effects, (3) evaluate the likelihood that those adverse effects will occur, (4)
estimate the risk, (5) apply management risk strategies from deliberate release, (6)
determine the overall risk of the GMO); European Union, Questions and Answers on the
Regulation of GMOs in European Union, Aug. 11, 2004, available at http://europa.eu.int/
comm/food/food/biotechnology/gmfood/qanda_en.pdf [hereinafter EU, Q & A].
203
EU, Q & A, supra note 207. The first instrument is Directive 90/219/EEC, as amended
by 98/81/EC, which regulates work on GM microorganisms in closed environments such
as laboratory research and work activities in laboratories. Id.; see also Council Directive
90/219/EEC, 1990 O.J. (L117/1), available at Westlaw at OJ 1990 L117/1; Council Directive
98/81/EC,1998 O.J. (L330/13), available at Westlaw at OJ 1998 L106/1. The second
instrument, Directive 2001/18/EC, regulates the experimental release of GMOs into the
environment and the placing of GMOs on the market. EU, Q & A, supra note 202; see also
Council Directive 2001/18/EC, 2001 O.J. (L106/1), available at 2001 WL 301L0018
[hereinafter Directive 2001/18]. Regulation (EC) No 1829/2003, the third instrument,
regulates the placing of GMO food or feed on the market. EU, Q & A, supra note 202; see
also European Parliament and Council Regulation (EC) No1829/2003, 2003 O.J. (L268/1),
available at Westlaw at OJ 2003 L268/1 [hereinafter Reg 1829/2003]. The fourth main
instrument, Regulation (EC) No 1946/2003, regulates the intentional and unintentional
movement of GMOs between EU member states and third countries. EU, Q & A, supra note
202; see also European Parliament and Council Regulation (EC) No 1946/2003, 2003 O.J.
(L287/1), available at Westlaw at OJ 2003 L287/1.
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2001/18/EC,204 introduces the principles of environmental risk
assessment.205 This Directive also calls for member states to establish a
regulatory scheme that mandates post-marketing monitoring
requirements, mandates information to the public, and requires that
member states ensure GM foods be labeled and traceable at all stages.206
Member states must consult with Scientific Committees and consult with
the European Parliament in determining whether to authorize the release
of GMOs, with the possibility that the Counsel of Ministers could change
the decision of a member state by a qualified majority vote.207
Not only is labeling part of Directive 2001/18/EC, but the European
Union has also passed several more specific regulations regarding
traceability and labeling of GM foods.208 Regulation (EC) No 1830/2003
requires that the operator sending a product containing GMOs ensure to
send the receiver of the product information, in writing, that the product
contains GMOs.209 A product containing GMOs must also have a unique
identifier.210 In the case that the product was produced by GMOs, the
operator must transmit to the receiver of the product an indication of
which ingredients or materials of the product were produced from
GMOs, if the information is available, and otherwise to transmit the
general message that the product is produced from GMOs.211 For prepackaged products containing or consisting of GMOs, the label on the
product must have on its label the following: “This product contains
genetically modified organisms” or “This product contains genetically
modified organisms [name of organism(s)].”212 Furthermore, products
going to the final consumer that are not packaged must have information
permanently and visibly displayed next to the product.213 These labeling
Directive 2001/18, supra note 203.
EU, Q & A, supra note 202; see also Directive 2001/18, supra note 203.
206
EU, Q & A, supra note 202; see also Directive 2001/18, supra note 203.
207
EU, Q & A, supra note 202; see also Directive 2001/18, supra note 203.
208
EU, Q & A, supra note 202; see also Directive 2001/18, supra note 203. Regulations are
different from directives in that regulations are specific laws that govern every member
state in the EU, whereas directives are objectives given to each member state that can be
enforced in different ways by each member state. KLAUS-DIETER BORCHARDT, THE ABC OF
COMMUNITY LAW 65 (2000).
209
EU, Q & A, supra note 202; see also Directive 2001/18, supra note 203; European
Parliament and Council Regulation (EC) No 1830/2003 Amending Directive 2001/18/EC,
2003 O.J. (L268/24), available at Westlaw at OJ 2003 L268/24.
210
EU, Q & A, supra note 202; see also Directive 2001/18, supra note 203.
211
EU, Q & A, supra note 202; see also Directive 2001/18, supra note 203.
212
EU, Q & A, supra note 202; see also Directive 2001/18, supra note 203; Reg 1829/2003,
supra note 203.
213
EU, Q & A, supra note 202; see also Directive 2001/18, supra note 203; Reg 1829/2003,
supra note 203.
204
205
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and traceability requirements would only apply to products containing
GMOs in the amount of 0.9% and above.214
The European Union believes that its new labeling laws demonstrate
that it has lifted the moratorium on GM foods, yet the United States has
decided to continue to pursue the dispute against the European Union at
the WTO because the United States believes the labeling restrictions are
still too prohibitive to trade.215 Because of the philosophical differences
between the EU and U.S. systems, accord seems difficult. However,
agreement is not impossible and a compromise on the part of the United
States would reconcile many of the labeling discrepancies to the benefit
of both the European Union and the United States.216 Part IV of this Note
discusses in greater detail how this reconciliation is possible.217
2.

Voluntary Disclosure

Although the FDA does not currently mandate labeling of GM foods,
it does give guidance as to how to label foods voluntarily in the
Guidance for Industry Voluntary Labeling Indicating Whether Foods
Have or Have Not Been Developed Using Bioengineering Draft
Guidance (“Guidance”).218 The Guidance gives examples of how a
company who wants to say that its product is genetically engineered
may label the product in ways that are not misleading.219 The Guidance
also notes that most “consumers would prefer label statements that
disclose and explain the goal of technology,” such as, “This product
contains high oleic acid soybean oil from soybeans developed using
biotechnology to decrease the amount of saturated fat.”220 However, in
describing the goal, the labels must not be misleading.221 For example, if
a label contains “These tomatoes were genetically engineered to improve

EU, Q & A, supra note 202.
See supra notes 174-79 and accompanying text (describing the status of the current
debate between the EU and the United States).
216
See Genetically Engineered Right to Know Act, H.R. 2916, 108th Cong. (2003). This bill
would have mandated the labeling of GM foods. Id.
217
See infra Part IV.
218
See generally U.S. FOOD AND DRUG ADMINISTRATION CENTER FOR FOOD SAFETY AND
APPLIED NUTRITION, Guidance for Industry Voluntary Labeling Indicating Whether Foods
Have or Have Not Been Developed Using Bioengineering (2001), available at
http://www.cfsan.fda.gov/~dms/biolabgu.html (last visited Jan. 30, 2004) [hereinafter
Guidance].
219
Guidance, supra note 218. For example, a label could say “Genetically engineered” or
“This product contains cornmeal that was produced using biotechnology.” Id.
220
Id.
221
Id.
214
215
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texture,” the label would be misleading if the consumer would not be
able to notice a textural difference.222
The Guidance also gives suggestions to companies that want to
indicate to consumers that their product does not contain GM foods.223
The FDA suggests that because many people do not know the acronyms
GMO or GM, the label should spell out the meaning of this
information.224 The FDA also suggests that “GMO free” be avoided for
several reasons besides its inclusion of an obscure acronym.225 First, the
phrase is not accurate because “genetically modified” is sometimes used
broadly to include conventional methods of food production.226 Second,
most foods do not contain organisms, so it is inaccurate to indicate that a
food product does not have organisms as it implies that some food
products do have organisms. And finally, “free” implies “zero,” which
may be difficult to substantiate, and all claims on labels should be
verifiable.227 The FDA gives suggestions of what would be appropriate,
including, “We do not use ingredients that were produced using
biotechnology” or “This oil is made from soybeans that were not
genetically engineered.”228 The FDA has further made clear that it does
not want any label to mislead people into thinking that foods that are not
genetically engineered are any better than those which are genetically
engineered.229
Id.
Id.
224
Id.
225
Id.
226
Id.
227
Id.
228
Id.
229
Id. (“[A] label statement that expresses or implies that a food is superior (e.g., safer or
of higher quality) because it is not bioengineered would be misleading.”). This approach
by the FDA clearly leaves open the possibility of lawsuits against food producers wanting
to show that their food is not GM. In fact, Monsanto brought just such a claim against
Oakhurst Dairy in July of 2003, suing it for deceptive labeling practices. See Bruce Mohl,
Got Growth Hormones? Dairies Play on Fear in Marketing Milk Without the Additive, THE
BOSTON GLOBE, Sept. 28, 2003, at J1. Oakhurst Dairy put the following label on its milk:
“Our farmers’ pledge: No artificial growth hormones.” Id. Monsanto claimed that the FDA
has recommended that labeling regarding this hormone should contextually or explicitly
indicate that there is no difference between use of the hormone or not, and because it does
not do this, it is deceptive. Matt Wickenheiser, Maine AG Steps in to Back Oakhurst,
PORTLAND PRESS HERALD, Aug. 28, 2003, at 1A. D. Mark Jackson, lawyer for the U.S.
Department of Labor in San Francisco, argued that Oakhurst has a First Amendment
freedom to disclose this information about their milk, and that it is not misleading because
enough information calls into question the scientific safety of this milk. D. Mark Jackson,
Why the First Amendment Protects a New England Dairy’s Right to Use a Milk Label Proclaiming
Its Product to Be Growth-Hormone-Free, FINDLAW, Aug. 14, 2003, at http://writ.corporate.
222
223
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The FDA’s approach to GM foods, including its position on
voluntary labeling of GM foods, together with the approach taken by the
European Union to mandate labeling of GM foods, are determinative to
the conclusions that GM foods should be labeled and that labeling GM
foods is consistent with the First Amendment.230 Likewise, the public
and scientific perceptions of GM foods as well as the general
governmental purposes for labeling are also pertinent to the conclusion
that GM foods should and may be labeled.231
III. ANALYSIS: THE UNITED STATES SHOULD MANDATE LABELING OF GM
FOODS
In order for Congress to mandate labeling, it must have the
constitutional authority to so legislate and the legislation must not be in
conflict with any other constitutional doctrine or provision.232 Congress
has already created legislation that gives the FDA the necessary
authority to mandate labeling of GM foods; however, it is not required
to, nor does it, use this authority.233 Therefore, because Congress has
significant reasons for requiring the FDA to mandate labeling of GM
foods, and doing so would not be counter to the First Amendment, it
should pass legislation that would accomplish this goal.234 However, in

findlaw.com/commentary/20030814_jackson.html.
Furthermore, consumer advocate
Ralph Nadar said the suit is “frivolous harassing litigation” and provided free legal advice
to Oakhurst through his foundation that supports free speech. Paul Livingstone & Matt
Wickenheiser, Nadar Enters Ring in Oakhurst Corner, PORTLAND PRESS HERALD, Aug. 14,
2003, at 1A. In 1994 Monsanto sued dairy farmers in Texas and Illinois over this same
issue, but settled after the companies changed their labels. Mohl, supra. Oakhurst Dairy
and Monsanto eventually settled the case when Oakhurst Dairy agreed to add “used” to its
label making it “Our farmers’ pledge: No artificial growth hormones used” and included
the disclaimer that the FDA has found no significant difference between cows treated with
BST and those not treated with the hormone. Beltway Notebook, FOOD CHEMICAL NEWS, Jan.
5, 2004, at 5.
230
See supra notes 159, 166; supra Part II.D.2; infra Parts III.A, III.B.
231
See supra note 96 and accompanying text (regarding Americans wanting labeling of
GM foods); see infra Parts III.A, III.B.
232
See supra text accompanying notes 101-03 (two-prong inquiry). Furthermore, in order
for the FDA to make rules mandating labeling, it must consider both its statutory authority
and the First Amendment. See supra note 150-53 and accompanying text (describing how
the FDA addressed both the statutory authority and the First Amendment in determining
that trans fats should be labeled).
233
See supra note 105 and accompanying text (describing the FDA’s authority to require
mandatory labeling and its refusal to do so).
234
See infra Parts III.A, III.B.
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so doing, Congress should make sure the legislation correlates to the
information available regarding GM foods.235
A. Establishing Statutory Authority
While the FDA continues to forgo the use of its authority to mandate
labeling of GM foods, Congress could pass measures that would require
the FDA to do so, and moreover, Congress should require the FDA to
mandate labeling of GM foods, based on a myriad of substantial
reasons.236 First, legislation requiring mandatory labeling of GM foods
would be economically beneficial for the United States because it would
reduce the transactional costs involved in trying to obtain information
regarding products that contain GM materials.237 Currently, unless
information is volunteered for marketing purposes, or unless consumers
or producers of multi-ingredient products have leverage to contractually
require producers to promise that their products will not contain genetic
engineering, consumers have no way of knowing if foods are GM.238
This lack of consumer power seriously limits manufacturers’ incentive to
produce the amount of food not containing GM materials that would be
demanded in the United States and Europe if all GM information
regarding foods were mandatorily disclosed. Full disclosure of this
information is essential to encouraging free markets.239
Additionally, transactional costs could increase if the public’s
confidence in the FDA is undermined, which could occur if the FDA
does not make GM labeling mandatory. Currently, Americans trust that
the FDA is regulating food properly and disclosing pertinent
information.240 However, people also feel that GM food should be
labeled accordingly.241 And, people are generally unaware of the fact

See infra Part III.C.
See supra note 105 and accompanying text (describing the FDA’s authority to require
mandatory labeling and its refusal to do so); supra note 88 (listing several expired bills that
would have regulated GM foods); infra text accompanying notes 237-68.
237
See supra text accompanying notes 138-44 (regarding disclosure decreasing
transactional costs).
238
See supra note 88 and accompanying text (listing many companies that are pledging to
not use GM foods); supra Part II.D.2 (discussing the Guidance on how to properly volunteer
information about genetic engineering on a product); supra note 83 (describing how
McDonald’s has a contract with farmers in which the farmers are not to use GM products).
239
See supra Part II.C.1 (discussing why governments mandate labeling).
240
See supra note 94 and accompanying text (regarding general trust in the FDA
regulation of GM foods).
241
See supra note 96 and accompanying text (describing the general view of Americans
that GM foods should be labeled).
235
236
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that much of the food that they are and have been consuming is GM.242
If people begin to become educated on this fact, and that education is not
by the FDA, they will foreseeably lose confidence in the FDA.243
Consequently, the public will feel that if it wants trustworthy
information, it has to find it on its own, which would increase
transactional costs within the market.244
Moreover, by mandating labeling of GM foods, the United States
would smooth the progress of international trade, which would help
resolve the dispute with the European Union.245 If the United States
were to require labeling, it could be in compliance with the directives set
forth by the European Union, dissipating the current dispute between
the United States and the European Union.246 The decision that the WTO
renders regarding this dispute will affect whether or not the United
States has the option to label products going to Europe, though it will
not necessarily resolve whether or not it is wise for the United States to
do so.247 Presumably, if the WTO finds that the ban has been lifted and
that the labeling laws are legitimate, the United States will have to
comply if it desires to legally sell food in Europe.248 If, however, the
WTO finds that the labeling is still effectively a moratorium, the result
might still be less than desirable for the United States because many
Europeans may just stop buying all food from the United States so as to
not risk buying GM foods.249
Furthermore, a decision rendered against the European Union
would leave an indelibly negative mark on Europeans’ view of the
United States. Although the release of GM foods into the market is only
242
See supra text accompanying notes 89-92 (describing how Americans generally do not
know they are eating GM foods).
243
The FDA required disclosure of irradiated foods because of consumer concern and
consumer expectations of the FDA. See supra notes 105, 145. The need for transparency in
regulation is essential to generating public trust. McGarity, supra note 32, at 477-78.
However, currently the FDA is not transparent as is demonstrated by its policies limiting
participation by and notice to the general public. Id. at 478.
244
See supra text accompanying notes 138-44 (regarding disclosure decreasing
transactional costs).
245
See infra text accompanying notes 245-54 (describing the potential for better trade
relations with the EU).
246
See supra text accompanying notes 200-214 (describing the EU’s labeling
requirements).
247
See supra Part II.D.1 (depicting the United States-EU dispute at the WTO).
248
See supra text accompanying notes 200-214 (describing the EU’s labeling
requirements).
249
This proposition is not unrealistic given the strong and active public sentiment against
GM foods in Europe. See supra notes 82-84 and accompanying text.
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one of many trade disputes that the United States currently has with
Europe, unlike trade conflicts between the United States and Europe on
other products, food is much more personal to the Europeans and also,
more visibly affects every European.250 Not only are Europeans greatly
concerned with food as a tradition, many also have heightened moral
interests and are perplexed with the many other complicated
implications of allowing this food.251 This concern has resulted in
grassroots action that the European politicians have been unable to
ignore.252 Consequently, it seems unwise for the United States to be
heavy-handed with Europe on this particular trade issue.253 If, on the
other hand, the United States decides to require full discloser, it might
eventually find that it is able to gain the trust of the European people
regarding GM products.254
Another reason policy makers should seriously consider requiring
the labeling of GM foods is that polls make clear that people in the
United States believe this type of information should be revealed. 255 For
that very reason, the FDA required that irradiation of foods be
disclosed—consumers thought the information was important.256
Similarly, the FDA should also disclose information as to whether food is
GM.
See Tony Capaccio, EADS Dispute Could ‘Taint’ Tanker Contest, Roche Says, BLOOMBERG
NEWS, Jan. 6, 2005, available at LEXIS, News Library, ALLBBN File (describing the debate
between the EU and the United States over government aid to plane makers); New Report
Points to a Number of “Significant” US Trade Barriers, EUROPEAN REPORT, Dec. 24, 2004, at
2924 (describing EU’s 20th annual report on U.S. trade barriers noting that the United
States has a long way to go in removing obstacles to transatlantic trade); Greider, supra note
82 (quoting Jeremy Rifkin who explains why biotech companies are having such a difficult
time in Europe).
251
See supra notes 70-73 and accompanying text (elaborating on an AEBC report).
252
See supra text accompanying note 83 (describing successful grassroots pressure in the
United Kingdom).
253
See supra notes 82, 177.
254
See supra note 84 and accompanying text (showing that European faith in GM foods is
not increasing). Thomas N. Urban, retired chairman and chief executive of Pioneer Hi-Bred
International, explains:
Monsanto forgot who their client was . . . . If they had realized their
client was the final consumer they should have embraced labeling.
They should have said, ‘We’re for it.’ They should have said, ‘We
insist that food be labeled.’ They should have said, ‘I’m the
consumer’s friend here.’ There was some risk. But the risk was a hell of
a lot less.
Kurt Eichenwald, Redesigning Nature: Hard Lessons Learned: Biotechnology Food—From the
Lab to a Debacle, THE NEW YORK TIMES, Jan. 25, 2001, at A1.
255
See supra note 96 and accompanying text (stating that Americans want GM foods to be
labeled).
256
See supra notes 105, 145 (describing FDA’s approach toward irradiated foods).
250
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The reasons people want to know information about GM foods lend
support to why Congress should require the FDA to mandate the
labeling of GM foods.257 Some people, such as the mother of the allergyplagued son described in the introduction of this Note, want to know
because they are concerned about possible adverse health affects.258
Although biotech companies argue that science has not shown any
health problems related to the genetic modification of foods, science has
also not shown that health problems are out of the realm of
possibilities.259 In fact, these new techniques may be creating more
detrimental allergies without detection.260 The safety and long-term
effects of genetic modification are simply unknown, and it is a logical
fallacy to think that, because nothing indicates harm thus far, safety can
be assumed.261 Thus, at the very least, people should be informed that
what they are consuming is new, because the safety of these foods has
not been proven by science.262
In addition to concerns about health, some people want to know
about genetic modification because of personal beliefs.263 Some are
morally opposed to genetic modification.264 For others, their religious

See infra text accompanying notes 258-67.
See supra notes 47-54 and accompanying text (describing health related concerns).
259
Compare supra note 59 and accompanying text (describing how some scientists believe
GM foods are more beneficial than conventional foods) with supra notes 47-54 and
accompanying text (describing possible health risks).
260
See supra notes 50-52 and accompanying text (regarding allergies).
261
See supra note 127 and accompanying text (containing Judge Leval’s argument for
caution); supra note 201 and accompanying text (regarding the precautionary principle). In
addressing the logical fallacy issue, Dr. Winfriend Corduan of Taylor University says:
We must be careful to avoid the fallacy of “appeal to ignorance” (ad
ignorantium): X has not been proven; therefore X is false; or X has not
been disproven; therefore X is true. So, science cannot take the absence
of proof or disproof to be an indicator of truth or falsehood, per se.
Email from Dr. Corduan, Professor of Philosophy and Religion, Taylor University (Oct. 6,
2003, 14:29:54 CST) (on file with author). Dr. Corduan qualifies this logical argument by
explaining that scientific claims are not made in isolation but are made within entire
systems of knowledge that are assumed without scientific proof. Id. For this reason, it
would be reasonable for a scientist to assume that atoms in Portugal behave in the same
way as those in Spain without empirical evidence. Id. It would also be reasonable to
assume that one need not believe a claim that the earth has a second moon without
empirical evidence. Id.
262
See supra notes 47-54, 62-68 and accompanying text (regarding possible health and
environmental problems with GM foods).
263
See supra notes 69-76 and accompanying text (describing personal belief objections to
GM foods).
264
See supra notes 71-73 and accompanying text (describing moral objections to genetic
engineering, particularly of animals).
257
258
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beliefs are in conflict with genetic modification.265 And still others have
misgivings based on philosophical ideas or concerns for the
environment.266 It is unreasonable that many people have belief-based
objections to GM foods and yet are denied access to information on GM
foods, even when food is so basic and necessary to survival that it is
unavoidable.267 Although the reasons Congress should require the FDA
to enforce mandatory labeling of GM foods are many, Congress must
ensure that labeling of GM foods be done carefully so as to avoid
infringement on First Amendment rights to free speech.268
B. The First Amendment Does Not Hinder Mandatory Labeling of GM Foods
Mandatory labeling of GM foods is essentially compelled
commercial speech.269 The Court in Zauderer used a very deferential
standard for compelled commercial speech where a state required
disclosures be added to existing marketing information provided by an
advertiser because that information would otherwise mislead the
See, e.g., supra note 72 (describing Buddhist objections to genetic engineering).
See supra notes 69, 74-80 and accompanying text (describing several ideological
objections).
267
McGarity, supra note 32, at 500-01. McGarity argues that consumers should be
informed on the food they are eating and be aware of any risks even if insignificant, rather
than having to trust paternalistic companies. Id. Consumers should have this knowledge
in case they have belief-based reasons to object. Id. Furthermore, these foods should be
labeled so that epidemiologists can study the effects on populations exposed versus
populations not exposed. Id. Dr. Marc Lappe agrees with Paul Thompson of Purdue that
consumers’ rights to get out of the system if they are opposed to GM foods is penultimate.
Lappe, supra note 53, at 40. Diane Thue-Vasquez explains some of the controversies
surrounding the issue of labeling GM foods as of 2000, and concludes that labeling GM
foods is ethically required. Diane Thue-Vasquez, Genetic Engineering and Food Labeling: A
Continuing Controversy, SAN JOAQUIN AGRIC. L. REV. 77 (2000).
268
See, e.g., supra notes 152-53 and accompanying text (describing how the FDA
addressed First Amendment concerns when mandating trans fatty acid labels).
269
Both Bolger and Rubin establish a strong argument that GM labeling is commercial
speech, particularly in light of the indicators discussed in Bolger—advertisement,
referencing specific products, and economic motivation. See supra note 108 (describing
how the Court has defined commercial speech). First, GM labeling is, or could be,
advertisement in many cases. In fact, the FDA gives directions to companies on how to
label their GM products for advertisement purposes. See supra Part II.C.2. However, even
where labeling of GM foods is not for the purpose of advertisement, GM labeling may still
be commercial speech. See supra note 108. Second, labeling of GM foods would reference
specific products—the food on which the labels appear. Finally, the main reasons that
agricultural companies would not want to include this type of labeling—alarming
consumers, impracticality of keeping crops separated, and frustrating biotechnology—are
all primarily economically based. See infra text accompanying notes 296-99. In other
words, labeling or not labeling specific information, such as GM or non-GM, bears on
whether or not a consumer will purchase the product and on other financial considerations.
See supra note 108.
265
266
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consumer.270 However, in the case of mandatory labeling of GM
products, the government may be requiring disclosure of information
where normally no information is provided at all, or where only the
basic information is provided, and thus the labeling would not
necessarily cure a problem of misleading advertising.271 Therefore, the
deferential Zauderer standard may be somewhat inappropriate for some
labeling requirements of GM foods, especially where the foods are not
already being advertised. The more stringent Central Hudson test will
thus be utilized in this Note to determine the constitutionality of
mandatory labeling of GM products.272
The first prong of the Central Hudson test, determining whether or
not the speech concerns lawful activity and is not misleading, is difficult
to apply to mandatory labeling.273 A company arguing that a law
mandating the labeling of GM foods violates the First Amendment
would not be saying that the company should be free to speak about its
product, but rather it would be arguing that the speech mandated by the
government misleads consumers.274 A court could respond to this
argument by the company in any of the following ways: (1) the
disclosure required by the statute is necessary to avoid speech that is
misleading, (2) the disclosure required by the statute is itself potentially

See text accompanying notes 116-20.
For example, tomatoes that are GM may be sold without packaging and simply placed
in a store with a sign designating them as “tomatoes.” Not designating the tomatoes as
“GM tomatoes,” though arguably misleading in that this information may be important to
a consumer’s decision to purchase or not, is not necessarily inherently misleading in the
same sense as discussed in Zauderer. Unlike in Zauderer where the attorney’s advertisement
for contingency-fee-based representation, which inaccurately implied no costs to the client
without success, not including “GM” with “tomatoes” does not somehow make the
tomatoes not tomatoes. It simply makes them a different kind of tomatoes than what
consumers likely expect. Of course, Zauderer may be more applicable for GM products that
are truly a mix of two different species but are advertised using only the name of one of the
species.
272
See supra notes 123-34 and accompanying text (discussing Amestoy); see also Borgner v.
Brooks, 284 F.3d 1204, 1206 (11th Cir. 2002) (applying the Central Hudson test to a state
disclosure requirement that mandated dentists to include a disclaimer with any
advertisement including specialty areas not recognized by the state or including non-state
approved credentialing organizations).
273
The Second Circuit did not address the first prong in Amestoy. However, had they
addressed it, the outcome would probably have been the same because at that time the
state law in Vermont was not congruent with the FDA on whether disclosure of the use of
GM products is necessary. Compare Int’l Dairy Foods Ass’n v. Amestoy, 92 F.3d 67 (2d Cir.
1996), with supra text accompanying note 193 (regarding the FDA’s decision that GM foods
are GRAS).
274
See infra text accompanying notes 296-99 (discussing potential arguments of biotech
companies against legislation requiring labeling of GM products).
270
271
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misleading, (3) the disclosure is not necessarily misleading nor is the
disclosure required to avoid being misleading.
If a court were to conclude that the disclosure required by the statute
is necessary to avoid a misleading message, it would uphold the statute
since the First Amendment does not protect misleading speech.275 If a
court were to conclude the disclosure required by the statute itself might
make the commercial message misleading, this threshold first prong
would not bar a claim challenging the statute, and the court would
continue the Central Hudson analysis, factoring in that the required
disclosure is potentially misleading.276 Finally, if a court were to find
that the disclosure mandated by the statute has no effect on whether or
not the commercial message is misleading, a claim challenging the
statute would not be precluded nor would the first prong weigh against
the government in the subsequent prongs of the Central Hudson analysis.
In addressing this first prong, courts should and most likely would
give deference to the government and determine that without the
mandatory disclosure the speech is misleading, if this were the
government’s basis for legislating.277 Given this great deference, the

275
See supra note 111 (describing how the First Amendment does not protect misleading
speech).
276
Arguably, the court in Amestoy followed this approach, though the court never
specifically discussed how the statute at issue faired under the first prong of Central
Hudson, but just went on to strike the statute down under the rest of the Central Hudson
analysis. See Int’l Dairy Foods Ass’n v. Amestoy, 92 F.3d 67 (2d Cir. 1996). This conclusion
is implied by the court’s conclusion that “[b]ecause Vermont has demonstrated no
cognizable harms . . . its statute is likely to be held unconstitutional.” Id. at 74.
277
See supra text accompanying note 197 (describing how the D.C. Circuit Court reviewed
the case against the FDA using only the scientific documentation to which the FDA had
access when making its decisions).
Not disclosing the GM nature of foods is misleading because science has not yet
determined the long-term effects of these products, people generally have no idea that they
are eating these foods, and in general people believe that this information is important. See
supra note 261 and accompanying text (explaining how not enough time has lapsed for
science to conclusively determine that all GM foods are safe); supra notes 90-91 and
accompanying text (showing that most people think they are not eating GM foods); supra
note 96 and accompanying text (describing how people think this information is
important). Even where companies who do not normally label the food at all, such as with
whole foods, companies would not be able to avoid at least a general labeling of a product,
such as “apple,” in which case Congress or the FDA could still argue that to not say that
the apple is GM is misleading, because most people would assume that it is not. But see
supra notes 271-72 and accompanying text (describing how using Zauderer is less prudent
for a statute mandating disclosure of GM foods than is Central Hudson because requiring
labeling of GM foods would be requiring speech where none was previously made in the
case of whole foods rather than regulating already existing speech).
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inquiry would be over because misleading speech (or non-speech) is not
protected and therefore the First Amendment claim against the statute
would be refuted.278
However, the court may find that GM foods not labeled as such are
not necessarily misleading. Currently, there is little if any proof that GM
products are fundamentally altered to ultimately be harmful.279 Rather,
the basis of legislation mandating disclosure of the GM nature of foods is
precaution: Sufficient time has not yet elapsed to confidently conclude
that the alterations made to the foods will ultimately not be harmful.280
Therefore, because science is not conclusive either way, a court could
reasonably conclude that mandatory labeling of GM foods is neither
necessary nor misleading and continue the Central Hudson analysis
considering other factors.
Upon continuing the Central Hudson analysis, a court should find
that mandatory labeling of GM foods satisfies the second part of the test,
which requires the government to have a substantial interest in requiring
disclosure of the GM status of foods.281 The government has several
substantial interests: reducing transactional costs—including decreasing
the likelihood of increased transactional costs, eliminating trade issues
with Europe, increasing European consumer confidence in GM products,
and providing information consumers want to know and feel is
important.282
These interests are substantial because they affect
One potential conflict arises where a state mandates speech requiring disclosure that
the federal government explicitly concludes is not necessary to avoid misleading
consumers. See, e.g., Amestoy, 92 F.3d 67 (2d Cir. 1996). However, the statute this Note
proposes does not face this issue as it puts forth that the federal government, rather than
states, should issue the statute requiring labeling of GM foods.
The problem of illegality is not present in this situation, however it could arise if the
United States made any GM foods illegal. See supra note 88 (describing bills proposing
tighter regulation); supra note 111 (describing how speech that encourages illegal activity is
not protected by the First Amendment).
278
See supra note 111 (describing how the First Amendment does not protect misleading
speech); see also Zauderer v. Office of Disciplinary Counsel of Supreme Court, 471 U.S. 626
(1985). The Court in Zauderer first determined whether the advertisements as presented
without certain disclosures were misleading. Id. at 639-40.
279
See supra notes 54, 59 and accompanying text.
280
See supra note 132 (Judge Leval’s argument for caution); supra note 261 and
accompanying text (regarding the logical fallacy of assuming safety simply because there is
no proof of harm).
281
See supra text accompanying note 112 (stating the second prong of the Central Hudson
test).
282
See supra text accompanying notes 236-67 (describing reasons Congress should
mandate labeling); see also Genetically Engineered Right to Know Act, H.R. 2916, 108th
Cong. § 2 (2003).
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fundamental aspects of American life in both financial and ideological
ways.283
In light of these interests, the Second Circuit erred in Amestoy by
holding that mandatory disclosure of a GM hormone in milk failed the
second prong of the Central Hudson test.284 First, the court overlooked
many of the reasons offered by Vermont as to why the statute was
substantially important when it concluded that Vermont’s only purpose
in requiring such labeling was “consumer curiosity.”285 The dissent in
Amestoy made clear that Vermont did not just require labeling of GM
hormones in milk to suffice consumer curiosity, but also because of the
possible adverse health affects to people, health risks to cows, negative
economic impacts, and philosophical objections—all clearly substantial
reasons as they affect the life, liberty, and livelihood of the citizens of
Vermont.286 Second, the court in Amestoy was clearly wrong in not
emphasizing the purpose of protecting commercial speech—to facilitate
disclosure.287 Although it may not be appropriate to use Zauderer
exclusively to determine the constitutionality of mandatory labeling of
all GM foods, the basic point it makes is certainly useful in this second
prong of Central Hudson: Because the importance of disclosure was the
reason the Supreme Court extended First Amendment protection to
commercial speech in the first place, a law requiring disclosure of the
GM status of foods would in no way conflict with that purpose, and in
fact would promote it.288

283
Along these same lines, people have the right to know whether food is GM or not
based on the Due Process Clause of the Fourteenth Amendment. See supra note 191
(describing Fisher’s Fourteenth Amendment argument). Food is basic to life. The FDA has
secured the faith of the people that it is properly regulating food in the United States and is
providing the public with all material information regarding food. See supra note 94 and
accompanying text. And yet, the FDA leaves a great deal of discretion up to biotech
companies, who are self-interested rather than consumer interested. See supra text
accompanying note 187 and note 194 and accompanying text. Also, the FDA does not
require disclosure of any information regarding genetic modification, even though people
obviously want it. See supra notes 96, 105 and accompanying text. This lack of disclosure is
an omission of a material fact on an essential aspect of life—food. See supra note 191.
284
See supra text accompanying note 124 (describing the holding in Amestoy).
285
See supra text accompanying notes 125-32 (describing the dissent in Amestoy).
286
See supra text accompanying notes 126-32; supra note 191 (containing Fisher’s
Fourteenth Amendment argument).
287
See supra text accompanying note 132; note 108 and accompanying text (describing
how commercial speech was originally protected because of the value of free flow of
information).
288
See supra text accompanying notes 116-20 (discussing Zauderer); supra note 108 and
accompanying text (discussing the purpose of protecting commercial speech); see also Int’l
Dairy Foods Ass’n v. Amestoy, 92 F.3d 67, 81 (2d Cir. 1996) (Leval, J., dissenting) (“They
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Furthermore, the substantial interests raised by the government in
Amestoy are even more significant today. Since Amestoy was decided in
1996, the undisclosed presence of GM foods has become a greater public
concern.289 Further scientific responses to GM foods also make it more
obvious that its safety is contested within the scientific community.290
Therefore, a court would have a much more difficult time overlooking
and down-playing these concerns than did the court in Amestoy. Because
the government will not be able to ignore the pressing concerns that
genetic modification raises, and because mandatory labeling would only
facilitate disclosure furthering the goals of the First Amendment, the
government has a substantial interest in requiring disclosure of the GM
status of foods.291
Mandatory labeling also survives the third prong of the Central
Hudson test, whether the labeling would directly and significantly
advance the government’s interests.292 One goal of the government is
disclosure, which depends on truthful, accurate, and trustworthy
information being presented to the public.293 Requiring that companies
themselves disclose the GM content of their own products would be the
most effective and accurate way for the government to accomplish this
goal.294
Nevertheless, biotech companies argue that the government’s
substantial interests would not be furthered for several reasons.295 First,
they argue that there is no legitimate reason to label GM foods because
the foods are substantially equivalent, so labeling would just confuse or
mislead the public into believing illegitimate fears regarding GM foods,
rather than provide them with meaningful information.296 Biotech
invoke the Amendment’s protection to accomplish exactly what the Amendment
opposes.”); Adrian Michael Simm, D.D.S. v. Louisiana State Bd. Of Dentistry, 2002 U.S.
Dist. LEXIS 1299, * 19-20 (using Zauderer to inform the state’s interest in a disclosure
requirement it was analyzing under Central Hudson).
289
See supra note 96 and accompanying text (regarding polls indicating Americans’ desire
for disclosure).
290
See supra notes 77-80 and accompanying text (describing disagreement in the scientific
community on the notion of substantial equivalence).
291
See supra text accompanying notes 237-68 (describing the reasons Congress should
mandate labeling of GM foods).
292
See supra note 113 and accompanying text (the third prong of the Central Hudson test).
293
See supra text accompanying notes 139-47 (describing why governments mandate
labeling in general).
294
See supra notes 140-44 and accompanying text (describing how the overall
transactional costs are lowest when companies have the burden of providing information).
295
See infra text accompanying notes 296-99.
296
McGarity, supra note 32, at 499-500.
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companies could also argue that the result of such labeling would be a
loss in sales for U.S. farmers and food processors of GM products.297
Furthermore, mandating labeling would be costly because it would
require that GM foods be kept separate from non-GM foods throughout
all stages of transport.298 Finally, biotech companies could argue that the
labeling of GM foods would just impede the progress of
biotechnology.299
These arguments by biotech companies inaccurately describe the
current status of GM foods as well as how labeling GM foods would
actually affect the market. First, mandatory labeling of GM foods would
provide meaningful information to consumers. Not all scientists agree
with the FDA’s assumption that all GM foods are GRAS.300 Consumers,
many of whom are also concerned with whether GM foods are in fact
just like traditional foods, should not be forced to trust biotech
companies, but should be made aware of any possible risks.301
Furthermore, the public has concerns beyond just the equivalency of GM
foods, and thus disclosure is important regardless of whether the end
product is vaguely regarded as “substantially equivalent.”302
Second, mandatory labeling would not necessarily result in the loss
of sales for U.S. farmers and food processors. In fact, labeling in
compliance with the European Union’s standards may increase sales by
U.S. farmers and food processors because it would help open the

297
Carter, supra note 83 (describing how McDonald’s has made it a policy to use only
non-GM beef in Europe due to consumer concern).
298
McGarity, supra note 32, at 501.
299
An unidentified official from the U.S. government said that the new labeling laws of
the EU “are calculated to frustrate the development of biotechnology.” Brian McGee, U.S.
May Challenge New EU Gene-Label Rules at WTO, WSJ Reports, BLOOMBERG NEWS, July 15,
2003, available at LEXIS, News Library, ALLBBN File.
300
See supra text accompanying notes 77-80 (discussion on substantial equivalence). The
FDA most likely decided that GM foods are GRAS based on suggestions from biotech
companies. See supra note 194 and accompanying text; see also McGarity, supra note 32, at
500.
301
See, e.g., note 50 and accompanying text (describing allergens as a potential problem
with GM foods).
302
See supra notes 69-80 and accompanying text (describing philosophical and moral
objections to GM products). Although the precautionary principle more naturally leads to
required disclosure, substantial equivalency need not necessarily preclude it, particularly
in light of the non-health related concerns people may have regarding GM foods. See supra
notes 69-80 and accompanying text.
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European market to U.S. farmers and food processors, even for food that
contains GM material.303
Third, the cost to producers to keep the foods separated would not
be terribly difficult, as is currently demonstrated by organic farmers.304
Also, this separation of GM foods from non-GM foods would help
facilitate systems of tracking GM foods, which some scientists have
suggested be created for monitoring purposes, and which the European
Union has already implemented for GM products in Europe.305 This
type of system would help detect some of the potential long-term effects
that no amounts of immediate testing would be able to provide.306
Therefore, the additional transactional cost of keeping these foods
separated is offset by the omission of the transactional cost that biotech
companies should be paying in long-term pre-market testing expenses,
but currently are not because they have instead decided to test their
products out on the public.307 The government should at least be able to
track these foods so that it can obtain the results from the live testing.
Furthermore, the reduction of other transactional costs relating to
unimpeded information flow and consumer confidence in government
regulation would outweigh any market damage resulting from
requirements that companies keep GM foods separate from non-GM
foods.308

303
See supra text accompanying notes 245-54 (regarding tension between the United
States and the EU).
304
McGarity, supra note 32, at 501; see also supra Part II.C.2 (demonstrating that the FDA
gives guidance on voluntary labeling of GM foods, thus assuming that some companies are
able to and do label as such).
305
See Genetically Engineered Pharmaceutical and Industrial Crop Safety Act of 2003,
H.R. 2921, 108th Cong. (2003) (prohibiting the cultivation of genetically engineered
pharmaceuticals in the open air and to create a tracking system to regulate pharmaceutical
and industrial crops); supra text accompanying notes 57-58 (describing a method for
facilitating future research on the effects of GM foods through a tracking system); supra text
accompanying notes 208-14 (describing the EU’s requirement that GM food not only be
labeled, but also tracked).
306
See supra note 131 and accompanying text (describing Judge Leval’s point regarding
the newness of many biotech techniques). Some people argue that by approving GM foods
based on analogy rather than testing, manufacturers treat humans like involuntary guinea
pigs. McGarity, supra note 32, at 498. If this testing is going to take place, at the very least
the products could be carefully monitored so that any future effects can be more clearly
understood and remedied.
307
See supra note 111 and accompanying text (stating that misleading information has no
First Amendment protection).
308
See supra note 143-44 and accompanying text (discussing how companies bearing the
information burden is most economically efficient).
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Finally, labeling would not necessarily impede the progress of
biotechnology. On the contrary, labeling would more likely result in
increased trust in the FDA and awareness by the public, who would
have no reason not to support such efforts if the benefits to them would
truly outweigh the risks.309 If there are substantial risks that biotech
companies just do not want to reveal, then the biotech companies’
refusal to disclose operates as providing misleading information, which
is not protected by the First Amendment in any case.310
Lastly, mandatory labeling survives the fourth prong of the Central
Hudson test because the regulation would be no more extensive than is
necessary to serve the government’s interests.311 Mandatory labeling
would serve so many different substantial governmental interests that a
biotech company would have a difficult time arguing that mandatory
labeling is more extensive than necessary to serve all of those interests.312
Basically, a successful argument would require independent showings
that the government could achieve each of its substantial interests in
some way besides mandatory labeling.313
It is unlikely that the biotech industry would be able to make these
independent showings. First, the overall transactional costs would be
decreased with mandatory labeling.314
The only alternative to
mandatory disclosure is voluntary disclosure based on market
demand.315 In fact, consumer demand has already resulted in many
companies producing foods that are labeled “non-GM.”316 However,
when these companies have tried to convey the message to consumers
that their food is not GM, biotech companies have muscled lawsuits
against them saying the message is misleading because there is no
309
People in the United States are generally not opposed to the idea of GM foods, and so
unless there really is great danger, people would likely be fine with progress of GM
technology. See supra text accompanying note 86. On the other hand, not much more
damage could be done for the image of biotech companies in Europe, and disclosure would
seem to be the first step towards gaining the trust of European people. See supra text
accompanying notes 82, 254.
310
See supra note 111 and accompanying text (stating that misleading information has no
First Amendment protection).
311
See supra text accompanying note 114 (the fourth prong of the Central Hudson test).
312
See supra Part III.A.
313
See supra text accompanying note 114 (the fourth prong of the Central Hudson test).
314
See supra text accompanying notes 143-44 (discussing how overall it is most
economically efficient for companies to bear some of the information burden).
315
The biotech industry might argue that if enough consumers demand labeling of GM
foods, then the market will supply them, as it did for Kosher and organic foods, and thus
labels need not be mandated. McGarity, supra note 32, at 501.
316
See supra note 88 (listing companies who provide non-GM foods).
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difference between GM and non-GM foods.317 Thus, this less restrictive
alternative that is currently in place—allowing the market to dictate the
information that companies disclose to the public—not only increases
transactional costs, it also hinders the government’s substantial interest
in disclosing information to the public about which the public is
concerned by inviting lawsuits.318 This less restrictive alternative does
not accomplish the government’s interests, and thus, is not an alternative
at all.
Next, there is no less restrictive way to eliminate trade issues
regarding GM foods with Europe.319 The only other way to eliminate
these issues is to receive a decision from the WTO that Europe has to
take the GM foods without restriction by labeling.320
European
consumers would still lack faith in U.S. produce and would only be
purchasing from the United States out of necessity or lack of
information. Even then, European countries could create and enforce
place of origin labels and individual European consumers could simply
ban all U.S. produce.321 So, even if the WTO were to force Europe to take
U.S. GM food products without labels, U.S. food would only be further
undermined and the trade issues would not really be solved.
In sum, in applying the Central Hudson test to a statute mandating
labeling of GM foods, any First Amendment conflict would be minimal
at best.322 The Central Hudson test is the most appropriate test to
determine the constitutionality of mandatory labeling of GM foods.323
The first part of Central Hudson either does not apply or would result in a
favorable ruling for the government if an agricultural company
questioned legislation mandating labeling.324 The government has many
substantial interests in requiring the disclosure of GM information,

317
See, e.g., supra note 229 (describing the lawsuit Monsanto brought against Oakhurst
Dairy).
318
See supra text accompanying notes 236-68 (describing the government’s substantial
interest in requiring disclosure).
319
See supra text accompanying notes 245-54 (regarding tension between the United
States and the EU).
320
See supra text accompanying notes 247-49 (discussing how a WTO decision for the
United States will not necessarily solve the problem).
321
See supra text accompanying notes 248-49; see, e.g., Tariff Act of 1930, 19 U.S.C. § 1304
(2000).
322
See infra text accompanying notes 323-26; supra text accompanying notes 106-07.
323
See supra text accompanying notes 270-72 (describing how Zauderer might be
applicable, but using the Central Hudson test for this analysis is more comprehensive).
324
See supra text accompanying notes 273-80 (discussing application of the first prong of
Central Hudson).
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which are directly and significantly advanced by disclosure.325 And, the
government has no less restrictive way to accomplish all of its goals.326
Therefore, as long as the labeling mandated by the government is not
misleading, it is reasonable to conclude that it would be upheld.
C. The Recently Expired Proposal for Labeling GM Foods
In 2003, the bill GERKA was proposed to the House of
Representatives.327 If enacted, this bill would have required the
following additions to the FFDCA:
(a) IN GENERAL- Section 403 of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 343) is amended by adding
at the end the following paragraphs:
`(w)(1) If it contains a genetically engineered material, or
was produced with a genetically engineered material,
unless it bears a label (or labeling, in the case of a raw
agricultural commodity, other than the sale of such a
commodity at retail) that provides notices in accordance
with the following:
`(A)
A
notice
ENGINEERED.’

as

follows:

‘GENETICALLY

`(B) A notice as follows: ‘THIS PRODUCT CONTAINS A
GENETICALLY ENGINEERED MATERIAL, OR WAS
PRODUCED WITH A GENETICALLY ENGINEERED
MATERIAL.’
`(C) The notice required in clause (A) immediately
precedes the notice required in clause (B) and is not less
than twice the size of the notice required in clause (B).
`(D) The notice required in clause (B) is of the same size
as would apply if the notice provided nutrition
information that is required in paragraph (q)(1).

See supra text accompanying notes 281-310 (giving a summary of the government’s
reasons and accomplishments in requiring disclosure).
326
See supra text accompanying notes 311-21 (explaining how mandatory disclosure is the
least restrictive way to accomplish the government’s goals).
327
Genetically Engineered Right to Know Act, H.R. 2916, 108th Cong. § 2 (2003).
325
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`(E) The notices required in clauses (A) and (B) are
clearly legible and conspicuous.328
The following label shows the relative sizes of information that the
bill would have required:

GENETICALLY
ENGINEERED

THIS PRODUCT CONTAINS A
GENETICALLY ENGINEERED
MATERIAL, OR WAS PRODUCED
WITH A GENETICALLY
ENGINEERED MATERIAL

Nutritional Facts
Serving Size ½ cup (31g)
Servings Per Container about 6

In addition to the requirement that foods containing GM products or
that were created by GM processes contain this label, the bill provided
that foods containing adventitious genetically engineered material
would only be considered genetically engineered if it contained over one
percent genetically engineered material.329
This bill was positive in many ways.330 First, because the bill
requires disclosure, it appropriately would reduce the transactional costs

Id. § 3.
Id. Some other aspects to this bill worth noting include the following: it does not
apply to restaurant food, it requires periodic testing of food to determine accuracy of
labeling, and the consequence of misbranding is civil penalties. Id. Also, if this bill were
enacted, it would require changes to the Federal Meat Inspection Act and the Poultry
Products Inspection Act to ensure mandatory labeling of meat and poultry food if it
contains genetically engineered material or if it was produced with genetically engineered
material. Id. §§ 4-5.
330
See infra texts accompanying notes 331-35.
328
329
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generated by inconsistent and voluntary labeling.331 Second, the bill’s
one percent or less requirement for adventitious GM material is similar
to the European Union’s system of labeling, and thus is a step towards
compliance with the European Union’s requirements; however, updating
the bill for compliance with European Union would require labeling of
products containing 0.9% GMOs or greater.332 Third, the bill’s required
disclosure for not only food that contains genetically engineered material
but also food produced by genetic engineering, regardless of the
presence of GM material, is a positive requirement for two reasons.333
The European Union requires disclosure of foods produced by genetic
engineering, so including similar disclosure in U.S. labeling laws helps
make U.S. products comply with the EU requirements.334 Also, this
requirement not only accommodates those people who are opposed to
the presence of GM material in their food, but also appeals to those people
who oppose, for ideological reasons, the process itself.335
Despite the several advantages of GERKA, the bill did not
satisfactorily achieve its main purpose—to accurately and completely
inform consumers.336 First, the bill should require that the label explain
the goal of the GM technology used in the product, in accordance with
the FDA’s point that most people want to know this information.337 This
sort of explanation would more completely accomplish the government’s
goal of disclosure for those people who want to know more than just
whether a product is GM.338 For example, a label stating, “This product
contains high oleic acid soybean oil from soybeans developed using
biotechnology to decrease the amount of saturated fat,” would inform a
331
See supra text accompanying notes 158-59 (describing reasons for regulating voluntary
disclosure).
332
See supra text accompanying note 214 (giving the EU percentage requirement).
333
See Genetically Engineered Right to Know Act, H.R. 2916, 108th Cong. (2003).
334
See supra text accompanying notes 211 (describing EU’s disclosure requirement for
foods produced using genetic engineering even if the food itself does not contain any GM
product).
335
See supra notes 69-80 and accompanying text.
336
One aspect to the bill that may need to be changed, though not addressed in this Note,
is the terminology used to disclose: “Genetically Engineered” is the proper terminology
according to the FDA. See supra text accompanying notes 218-29. However, the language
used by the European Union, at least in its English translation, uses “genetically modified,”
so if this bill is to have relevance in conforming U.S. law to that of the EU’s, it may need to
address this difference in wording if the European Union is as particular as the FDA about
the wording. See EU, Q & A, supra note 202.
337
See supra text accompanying note 220 (regarding the FDA pointing out that most
people want to know the goal of GM technology).
338
See supra Part II.C.1 (explaining the government’s reasons for mandating disclosure);
text accompanying note 220 (giving an FDA suggestion on how to provide the purpose).
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consumer who is primarily concerned that the point of the genetic
engineering is only to benefit a company’s profits, that the point of the
genetic engineering is also to directly benefit the consumer.339
Furthermore, a person concerned about allergies or other adverse health
effects related to GM foods could experiment with avoiding some, but
not all, GM foods, based on the assumption that it is a particular
modification that is causing an allergic reaction. A requirement that the
label disclose contact information or an avenue to obtain more specific
information would also help achieve the goal of increasing the amount of
information available to consumers.
Furthermore, the bill should not require that “GENETICALLY
ENGINEERED” be twice the size of the nutritional information.340 This
size requirement implies that the information is intended to serve as a
warning rather than as a general disclosure. Because science is still not
conclusive on the effects of GM foods, a warning is just as inappropriate
as no disclosure at all.341 Along the same lines, the bill should include a
section requiring that a food producer who wants to label a food to
indicate that it does not contain GM material must not suggest that the
food is safer, unless validated by science.342 This change would further
clarify that the intent of the bill is not necessarily to serve as a warning.
Because science is not conclusive regarding the safety of GM foods,
the purpose of requiring disclosure of GM food should be to provide the
public with unbiased information.
At this point, unbiased and
meaningful disclosure would be the only way to avoid the First
Amendment concern of misleading consumers.343
IV. MODIFICATIONS TO THE “GENETICALLY ENGINEERED RIGHT TO KNOW
ACT”
A modified version of the “Genetically Engineered Right to Know
Act” that conforms with the purpose of unbiased disclosure to the public
339
See supra text accompanying 220 (giving an FDA suggestion on how to provide the
purpose).
340
See supra text accompanying note 329 (stating the bill that would require
“GENETICALLY ENGINEERED” be twice the size of nutritional information on the label).
341
See supra note 261 (describing Professor Corduan’s analysis that care should be given
to avoid a logical fallacy).
342
See supra text accompanying note 229 (explaining that the FDA does not want to
mislead people into thinking that foods that are not GM are better than those foods that are
GM).
343
See supra note 111 and text accompanying (stating that misleading information has no
First Amendment protection).
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should be introduced to Congress.
Although the following
modifications would not necessarily fulfill all the requirements of EU, in
particular, it does not address requirements of traceability, it does
address the primary labeling discrepancies between the European Union
and the United States.344
First, a modified version of GERKA should require that the purpose
of the modification be included in the disclosure. Second, the bill should
require labeling and tracking of foods containing 0.9% GMOs or greater.
Third, the bill should require that contact information be included so that
consumers have a way to gather more information. Fourth, the bill
should require that the disclosure be the same size as nutritional
information, not twice as large. Fifth, the bill should include a section
describing how manufacturers must label foods if they choose to indicate
that they are not GM.
To effect these changes, § 3(a)`(w)(1) of GERKA should be changed
to read:
(a) IN GENERAL- Section 403 of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 343) is amended by
adding at the end the following paragraphs:
`(w)(1) If it contains a genetically engineered material, or
was produced with a genetically engineered material,
unless it bears a label (or labeling, in the case of a raw
agricultural commodity, other than the sale of such a
commodity at retail) that provides notices in accordance
with the following:
`(A)
A
notice
ENGINEERED.’

as

follows:

`GENETICALLY

`(B) A notice indicating the purpose of the genetic
engineering.
`(C) A notice offering a phone number, a mailing
address, an email address, or an internet site through
which more information can be obtained regarding the
See supra text accompanying notes 206, 208-14 (describing EU’s requirements of
traceability); supra note 88 (noting a bill parallel to GERKA offered in the House of
Representatives in 2003 entitled Air Cultivation of Genetically Engineered Crops, H.R.
2921, 108th Cong. (2003), which would more appropriately address the issue of tracking
GM products).

344
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product labeled, including information regarding the
use of genetic engineering on the product.
`(D) The notice required in clause (A) immediately
precedes the notice required in clause (B) and is the same
size as the notice in (B).
`(E) The notices required in clauses (A) and (B) are of the
same size as would apply if the notice provided
nutrition information that is required in paragraph
(q)(1).
`(F) The notices required in clauses (A) and (B) are
clearly legible and conspicuous.345
Commentary
The addition of section (a)`(w)(1)`(B) would accomplish the goal that
the purpose of the modification be included in the disclosure. The
addition of section (a)`(w)(1)`(C) would ensure that consumers have a
way to gather more information. Finally, the modification to sections
(a)`(w)(1)`(D) would decrease the size of “GENETICALLY
ENGINEERED,” so the label does not appear to be a warning. The
following illustrates how the label would look with these modifications:
GENETICALLY ENGINEERED
This product contains high oleic
acid soybean oil from soybeans
developed
using
genetic
engineering to decrease the
amount of saturated fat.
For more information call 123456-7890 or visit our website at
www.company.com.

Nutritional Facts
Serving Size ½ cup (31g)
Servings Per Container about 6
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Furthermore, § 3(a)`(w)(6) of GERKA should be changed to read as
follows:
`(6) For purposes of this paragraph and paragraph (x), a
food with respect to which a test has been identified
under subparagraph (5) shall not be considered to
contain a genetically engineered material if, as indicated
by such a test-`(A) the food does not contain any genetically
engineered material, or
`(B) the food contains an adventitious genetically
engineered material and the amount of the material in
the food is lower than 0.9 percent, except that a lower
percentage designated by the Secretary shall apply for
purposes of this subparagraph if the Secretary
determines that a test identified under subparagraph (5)
can detect a percentage lower than 0.9 percent.
`(x) If it bears a label indicating (within the meaning of
paragraph (w)) that it does not contain a genetically
engineered material, or that it was not produced with a
genetically engineered material, unless the label is in
accordance with regulations promulgated by the
Secretary. With respect to such regulations:
`(1) The regulations may not require such a label to
include any statement indicating that the fact that a food
does not contain such material, or was not produced
with such material, has no bearing on the safety of the
food for human consumption.
`(2) The regulations may not prohibit such a label on the
basis that, in the case of the type of food involved, there
is no version of the food in commercial distribution that
does contain a genetically engineered material.’
`(3) The regulation must require that such a label not
include any statement indicating or implying that a food
product is more or less safe because it is or is not
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genetically engineered, unless such information can be
substantiated by scientific research.346
Commentary
First, changing “one percent” to “0.9 percent” in section `(6)`(B)
would bring U.S. GM products more closely in line with the EU
standards.347 Moreover, the change to `(x)`(3) would improve section `(x)
by accomplishing disclosure of the most reasonable information to
consumers based on present scientific information.
Section `(x)`(1) of the original GERKA correctly makes clear that
companies who claim, through labeling, that their food is not genetically
engineered, must not be required to also make a disclaimer that this has
no bearing on the safety of the food. Such a disclaimer would be
improper because it would require companies to make a conclusive
statement that genetic engineering does not affect the safety of the
product, backed only by a lack of scientific information saying otherwise.
On the other hand, genetically engineered products are not necessarily
unsafe just because science has not positively concluded safety.
Therefore, in order to give consumers a more complete and accurate
picture of the current status of scientific understanding, which is
currently inconclusive but may become less so in the future, it is
important that `(x)`(3) be added to prohibit labels from making any
statements not substantiated by science.
V. CONCLUSION
Although the United States does not require GM foods to be labeled,
it should require labeling of GM foods because doing so would inspire
trust in consumers, who have legitimate reasons for desiring to know
this information. Mandatory disclosure by the United States would not
only provide information to consumers in the most efficient way, it
would also create more uniformity with the laws of European countries,
improving the United States’s foreign trade relations. Although the
expired bill, GERKA, correctly requires mandatory labeling of GM foods,
its specific requirements insufficiently capture the proper goal of the bill,
which is to accurately disclose information to consumers so that they
might make educated decisions when purchasing food. However, by
changing the size requirement of the information on the label, by
The proposed amendments are italicized and are the contribution of the author.
See supra note 214 and accompanying text (describing how the EU regulatory laws
require labeling and tracing of products with 0.9% GMOs or greater).
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requiring the label to disclose the purpose for using particular genetic
modifications and how to gain more information, and by prohibiting
unsubstantiated assertions on the label, GERKA can be modified to meet
this goal of providing consumers with accurate, non-misleading
information. Furthermore, by changing the percentage of GMOs
required for labeling to apply in order to conform with the European
Union’s standards, the bill would more completely open trade with the
European Union. The proposed amendments are the most reasonable
way of accomplishing these changes, and accordingly, would ensure that
a congressionally proposed version of GERKA would successfully
achieve the goal of educating consumers.
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